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Abstract
The colorectal cancer (CRC) survivor population is increasing in the United States. The
lack of effective dietary recommendations in recurrence prevention undermines the
health-related quality of life of survivors. Grounded in the socioecological model, dietary
behavior is a personal-level risk factor that individuals may control. This study
investigated the CRC-specific mortality risk as predicted by diet quality, dietary fiber
intake, and dietary fat intake in hope of contributing to future dietary recommendations.
A secondary analysis using data from 1,166 CRC survivors in the Multiethnic Cohort
Study was analyzed via Cox proportional hazard regression models to estimate mortality
risk. Results from the regression models found that postdiagnosis diet quality, as measure
by the Healthy Eating Index-2010, was not associated with CRC-specific mortality risk.
However, a change in scores from below-median to above-median from prediagnosis was
associated with an increased risk (HR = 2.00, 95% CI [1.02, 3.99], p = 0.044).
Meanwhile, dietary fiber intake of moderate and high levels was associated with 58% and
52% risk reduction (p = 0.011 and 0.041, respectively). Finally, neither total dietary fat
intake nor fat from fish and shellfish was associated with CRC-specific mortality risk.
The findings suggested a need to identify an effective tool to evaluate diet quality postCRC. Additionally, while dietary fiber intake was favorable in improving long-term
outcomes, dietary fat and fish consumption may not directly contribute to CRC-specific
mortality risk reduction during long-term survivorship. This study provided new evidence
on the dietary needs of minority CRC survivors and may shape public health education.
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1
Part 1: Overview
Introduction
Colorectal cancer (CRC) ranks third in incidence among newly diagnosed
malignancies in the United States. In 2020, the expected colon cancer cases will reach
104,610 and rectal cancer will exceed 43,000 cases (Siegel et al., 2020). However, early
detection and treatment advancements have led to improved survival rates, contributing
to a growing population of over one million CRC survivors in America in 2016
(American Cancer Society [ACS], 2020). Unfortunately, the disease burden is distributed
unequally across demographics. In the United States men experience a 30% higher
incidence rate and 40% higher mortality rate compared to women (ACS, 2017). From
2000 to 2013, CRC incidence increased by 22% and mortality rate by 13% in those who
were under 50 years of age (Siegel et al., 2017). Across racial groups, African Americans
carry the highest disease burden in both incidence and mortality rate, far exceeding that
of other races.
A host of risk factors have been linked to the development of cancer, in which an
estimated 20% of all cancers diagnosed in the United States were associated with lifestyle
choices such as alcohol consumption, physical inactivity, poor nutrition, excess body fat,
and smoking (World Cancer Research Fund [WCRF], 2018a). Epidemiological and
clinical data demonstrated a remarkable link between diet, cancer development, and
mortality risk (Wiseman, 2019). However, their relationship with cancer recurrence risk
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is less clear. As a result, the challenges faced by CRC survivors in setting evidence-based
dietary goals bear growing relevance in both clinical and public health settings.
Problem Statement
To date, the association between habitual diet patterns and CRC incidence and
mortality risk is well-established in the literature (WCRF, 2018b). Researchers observed
a lifetime incident risk reduction from consuming a healthy diet, a pattern high in plant
foods and low in red and processed meat and moderate in fat and alcohol, regardless of
genetic risk (Carr et al., 2018).
Although a healthy diet is encouraged, CRC patients may encounter multiple
barriers to achieving it. For example, in patients undergoing chemotherapy or radiation
therapy, side effects often include dry mouth, mouth sores, altered taste reception,
nausea, vomiting, and diarrhea (ACS, 2020), limiting their ability to eat. While the
majority of the side effects diminish upon treatment completion, some of them could
result in long-term smell and taste disorders, causing food aversions (Cohen, Wakefield,
& Laing, 2016). Furthermore, depending on the stage and location of the tumors, surgical
resection of the colon or rectum may necessitate reduced fiber intake to manage
gastrointestinal (GI) symptoms (Cha et al., 2012). Additionally, CRC survivors reported
physical, psychosocial, environmental, and economic challenges (Drury, Payne, & Brady,
2017; Santin et al., 2015) that may have long-term negative effects on dietary choices.
Compared to incident-CRC prevention, the evidence regarding diet and recurrentCRC prevention is inconclusive. While some researchers reported a null association
2
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between postdiagnosis diets and recurrence (Kohler et al., 2018), others have found
positive associations between postdiagnosis diet quality and cancer-free survival
(Guinter, McCullough, Gapstur, & Campbell, 2018; Schwedhelm, Boeing, Hoffmann,
Aleksandrova, & Schwingshackl, 2016). Consequently, there remains a sizable gap in the
existing literature as to whether dietary choices could be an effective deterrent to CRC
recurrence.
Purpose of the Study
My aim for this study was narrow the knowledge gap pertaining to the
relationship between dietary intake and mortality risk during CRC survivorship. The
manuscripts follow a central theme surrounding the relationship between postdiagnosis
dietary choices and CRC-specific mortality risk in survivors: (a) Diet quality and its
change, (b) Dietary fiber intake and its change, and (c) Dietary fat intake and its change
from pre-diagnosis level. The analyses will provide insights on how these components
influence CRC survivorship and whether changes from pre-diagnosis levels are
associated with mortality risk.
Framework
The socioecological model (SEM) by Bronfenbrenner (1977) theorizes that an
individual’s development results from multilevel influences. These influences begin with
the most direct and strongest impact from the micro- and mesosystems surrounding
personal characteristics and relationships. The next levels involve the exo- and
macrosystems that relate to institutional, societal, and policy components in a person’s
3
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development (Bronfenbrenner, 1989). In the context of health outcomes, the SEM’s
personal, interpersonal, organizational, community, and societal levels are an applicable
epidemiological framework (Sallis, Owen, & Fisher, 2008). For example, the Centers for
Disease Control and Prevention’s colorectal cancer control program demonstrated an
uptick in screening among hard-to-reach populations in a cost-effective manner through
an SEM-based approach (Kemper et al., 2018).
In cancer survivorship, each level in the SEM may affect either the recurrent or
mortality risk, or both (Figure 1). At the personal level, lifestyle choices contribute to
both CRC recurrence and mortality risk (Moore, Buchanan, Fairley, & Lee Smith, 2015;
Paul et al., 2016). At the interpersonal level, social support and relationship with
healthcare providers are significant drivers in postcancer self-care (Burg et al., 2015).
From the organizational perspective, workplace reintegration and medical cost were
reported as significant stressors in survivorship (Guy et al., 2015). Upstream are the
community and societal levels, such as food security, CRC surveillance guidelines, health
insurance status, and more (Ryerson, Eheman, Styles, Rycroft, & Snyder, 2015).
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Figure 1. CRC survivorship in the socioecological model.
The Multiethnic Cohort Study (MEC) investigates the relationship between
individual attributes and chronic diseases (University of Hawaii, 2020). The demographic
characteristics of participants were collected at baseline and follow-up surveys. For
participants diagnosed with CRC, information on the diagnoses and deaths were extracted
from state-level cancer registries. In the secondary data analysis, dietary choices were
examined for their association with CRC-specific mortality in survivors, controlling for
potential confounders such as body weight, physical activities, smoking status, and
education level. Given that such factors are often interconnected with social support and
environmental resources, the SEM was a suitable framework in guiding the study and its
future applications (Figure 2).
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Figure 2. Study variables at the personal level in the SEM construct.
Social Impact
Social cohesiveness relies on functional social units across all socioecological
levels. As cancer survivors account for 5% of the United States population (ACS, 2020),
they exert significant societal impact. Hence, effective strategies to reduce recurrent and
mortality risks can strengthen the survivor community and their extended spheres.
Furthermore, a lower CRC-specific mortality rate may also reduce healthcare expenditure
(El-Shami et al., 2015) by survivors.
The study on postdiagnosis dietary intake aligns with the personal level influences
on CRC-specific mortality risk in survivors. Data generated from this study may lead to
the identification of opportunities in improving survivorship care planning. Additionally,
the findings may guide public health campaigns in countering personal level barriers with
interpersonal, organizational, community, and policy level support.
6
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Background
Multiple risk factors contribute to the recurrence and mortality risks during CRC
survivorship. While genetics is a nonmodifiable risk factor, lifestyle choices such as diet,
physical activity, and smoking are modifiable and thus, critical components in risk
reduction investigation. In particular, diets high in fruits, vegetables, and whole grains
and low in fat, red and processed meat, alcohol, and added-sugar consumption were
correlated with reduced cancer recurrence, comorbidities, and mortality risk (Meyerhardt
et al., 2007; Zhu et al., 2013).
Previous qualitative research revealed CRC survivors’ attitudes toward dietary
changes (Hardcastle et al., 2017). Common themes that emerged included the desire to
return to the precancer lifestyle, uncertainty about the benefit of dietary changes,
skepticism of nutrition guidelines, lack of motivation, and personal health beliefs
(Hardcastle et al., 2017). Simultaneously, dietary advice has been indicated as a priority
by CRC survivors (Tan et al., 2019). To explore the impact of postdiagnostic dietary
changes, it was imperative to review the disease’s epidemiology, prevention, and the role
of diet.
Epidemiology
CRC is one of the most commonly diagnosed malignancies worldwide (WCRF,
2018a). In 2020, colon cancer will surpass 104,000 cases and rectal cancer to exceed
43,000 cases (Siegel et al., 2020). In 2016, nearly one and a half million Americans were
living with active or a history of CRC (ACS, 2017). Such incident rates equate to one in
7
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22 men and one in 24 women diagnosed with CRC (Siegel, Miller, & Jemal, 2016). The
survival rate is 65% at 5 years and 58% at 10 years postdiagnosis (NCI, 2016). In persons
diagnosed with localized adenocarcinoma, the 5-year survival rate was 90% (ACS, 2020).
Such gains in survival are attributed mainly to increased and earlier screening as well as
therapeutic advances (ACS, 2020).
Sex. Men experience about 30% higher incidence and a 40% higher mortality rate
related to CRC compared to women (ACS, 2020). Although the differences in sexes are
not fully understood, they may be partial reflections of lifestyle and biological factors
such as alcohol consumption, cigarette smoking, and sex hormones (Murphy et al., 2011).
Age. The median age at diagnosis is 68 in men and 72 in women for colon cancer
and 63 years old for both men and women for rectal cancer (ACS, 2020). However, there
is a rising trend among younger Americans. Between 2000 and 2013, Americans over 50
years old reported a decline of 32% in incidence (Siegel et al., 2017). Whereas, diagnosis
in adults under 50 years old had risen by 22% in the same period (Patel & Ahnen, 2018).
Mortality rates between 2005 and 2014 showed a similar pattern.
Race. Racial disparity exists in association with biological, social, and
environmental determinants (Augustus & Ellis, 2018). In 2013, the incidence rate among
African Americans was 51.1 per 100,000 population—a marked difference of 20% higher
incidence than non-Hispanic Whites and 50% higher than Asian Pacific Islanders (ACS,
2020). The mortality rates were 40% and 100% higher than that of non-Hispanic Whites
and Asian Pacific Islanders, respectively (ACS, 2020). Nationally, the incidence rates for
8
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Hispanics and Asians are 35.5 and 32.2 per 100,000, with mortality rates at 11.7 and
10.3, respectively. Since the mid-2000s, mortality rates have gradually declined at
roughly 2% per year for non-Hispanic Whites, Hispanics, and Asians, and by 3% per year
in African Americans (ACS, 2020). The slightly greater decline in mortality rate among
African Americans over a decade has narrowed the gap between races.
Preventive Efforts
The goal of CRC screening is early detection and removal of polyps to reduce
cancer incidence and mortality rates. Multiple professional organizations and public
health authorities including the U.S. Preventive Services Task Force (2016), the ACS
(Wolf et al., 2018), the American College of Gastroenterologists (Rex et al., 2017), the
American College of Physicians (Qaseem, Crandall, Mustafa, Hicks, & Wilt, 2019), and
the National Cancer Care Network (Provenzale et al., 2018) have released guidelines on
CRC screening. These guidelines are similar in their recommendations on the age of
initial screen, methods, and follow-up frequencies.
Screening guidelines. The ACS recommends an initial screening at 45 years of
age (Wolf et al., 2018). The frequency for screening is based on the chosen method, with
stool-based tests to be repeated every 1 to 3 years and structural examinations by
colonoscopy and sigmoidoscopy repeated every 5 to 10 years (Wolf et al., 2018). Both
the U.S. Preventive Services Task Force (2016) and ACS strongly recommend regular
screening through 75 years of age (Wolf et al., 2018). For individuals 76 to 85 years old,
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clinicians should base screening decisions on the individual’s risk level. The guidelines
do not recommend routine screening for those who are over 85 years old.
For individuals with increased risk, the American College of Gastroenterologists
2017 guideline addresses their screening needs (Rex et al., 2017). Those with a firstdegree relative documented for early-onset CRC or advanced adenomas, colonoscopy
screening may begin as early as 40 years old and repeated every 5 years. The guideline
also recommends that African Americans begin screening at 45 years old.
The Role of Diet
There is strong evidence that diet is associated with the initiation and progression
in and protection against CRC (Wiseman, 2019). Based on epidemiological and
mechanistic data, diet is estimated to contribute an estimated 47% of the modifiable risks
in CRC pathogenesis (Vieira et al., 2017). In CRC, dietary components directly interact
with colonic and rectal tissues during digestion and absorption (Song, Garrett, & Chan,
2015), heightening both the potentially harmful and protective properties of the diet.
Many dietary elements had been studied extensively over the past 3 decades in which
several types of food (whole grains, dairy), as well as nutrients (antioxidants, vitamin D,
calcium, fiber), had emerged as anticarcinogenic (Wiseman, 2019).
However, while many studies examined the association between habitual diet and
incident-CRC incidence and mortality risks, less is known regarding the dietary choices
of CRC survivors and their relationships with recurrence and long-term survival. This
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analysis investigated the role of diets among CRC survivors from the perspective of diet
quality, dietary fiber, and dietary fat intake.
Diet quality and dietary indices. Historically, nutrition research focused on
single-nutrients and their relationships with diseases, for example, vitamin C and scurvy,
iron and anemia, or protein and malnutrition. Over time, there was an increasing
recognition of nutrient interactions and the synergistic effect of whole foods and longterm dietary habits. The subsequent interest in quantifying diet patterns and quality led to
the development of dietary indices. To evaluate an individual’s diet quality, food intake is
often assessed by dietary recalls or food frequency questionnaires (FFQs), then calculated
into a score according to an index’s scoring system.
The Healthy Eating Index (HEI) is a frequently used evaluation tool to measure
compliance with the Dietary Guideline for Americans (DGA). The U.S. Department of
Agriculture (USDA) debuted the HEI in 1995 for diet quality assessment, which has
since been incorporated in many epidemiological studies (Kennedy, Ohls, Carlson, &
Fleming, 1995). The HEI is updated every 5 years to reflect changes to the DGA. The
2010 version, HEI-2010, was a collaborative update by the USDA and the U.S.
Department of Health and Human Services (Guenther, Casavale et al., 2013,). It contains
12 components and emphasizes food group the higher the conformity to the 2010 DGA
(Guenther, Kirkpatrick et al., 2013).
Dietary patterns that scored high on the HEI have shown promising results in
incident-CRC risk reduction. Schwingshackl, Bogensberger, and Hoffmann (2018)
11
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conducted a large-scale meta-analysis of cohort studies, investigating diet quality and
multiple health outcomes. The pooled analysis of 68 cohorts totaling 1.67 million
participants showed a 16% reduction in cancer incidence. Specific to CRC, there was a
23% reduction in combined incidence and mortality risk (Relative Risk [RR] = 0.77; 95%
CI [0.73, 0.81]). Nevertheless, no such association was found in survivors. Reedy et al.
(2008) compared HEI-2005 scores from participants in the National Health InstituteAmerican Association of Retired Persons (NIH-AARP) Diet and Health Study (N =
567,169) reported a 20% and 28% lower incidence risk in women and men, respectively.
Similarly, Vargas et al. (2016) found a 27% lower incidence risk in postmenopausal
women measured by the HEI-2010 from the Women’s Health Initiative (N = 161,808).
Meanwhile, in a case-control study (431 cases, 726 controls), Miller et al. (2010) reported
a 56% reduced incidence risk in women and 44% in men associated with high-quality
diets measured by the HEI-2005.
Despite the large sample size of many cohorts, data on racial minorities are
scarce. As a result, the MEC was initiated to address questions regarding nutrition and
cancer (Kolonel et al., 2000). The study enrolled over 215,000 participants from the state
of Hawaii and Los Angeles County, California. Since 1993, participants were surveyed
every 4 to 6 years (University of Hawaii, 2019). Park, Boushey, Wilkens, Haiman, and
Le Marchand (2017) examined baseline diet quality and incidence CRC risk in 190,949
participants (49,443 Japanese Americans, 26,719 African Americans, 35,991 Latinos,
12,338 Native Hawaiians, and 43,318 non-Hispanic Whites); extreme quintiles
12
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comparison showed a 21% reduction in incidence risk in Japanese Americans, Latinos,
and non-Hispanic Whites who scored in the top quintiles on the HEI-2010.
The observed reduction in incidence-CRC and mortality risks associated with the
HEI score was consistent across several cohorts. As such, it is reasonable to extend the
HEI’s application in recurrent-CRC mortality risk assessment investigation.
Dietary fiber. Dietary fiber is indigestible complex carbohydrates that are
fermented by bacteria in the GI tract. The relationship between dietary fiber and CRC
incidence and mortality risks is mediated by the physical properties of fiber and its
influence on the gut microbiota. Fiber is known to increase stool consistency and colonic
motility, thus reducing carcinogens’ exposure to colonocytes (Perry & Ying, 2016). In
the colon, diet residuals including a small amount of protein, fatty acids, primary bile
acids, and undigested carbohydrates undergo bacterial fermentation. During this process,
fiber fermentation produces short-chain acids, including butyrate, yielding vital
metabolites that strengthen the immune functions of the GI tract. Butyrate has antiinflammatory and antineoplastic properties and is the preferred energy source in
colonocytes in the luminal mucosa. Bacterial fermentation supports homeostasis,
modulates immune responses, and regulates epigenetic expression in the microbiota
(O'Keefe, 2016). In contrast, a low fiber, high protein diet increases protein fermentation
and bile acids deconjugation in the colon, which promotes a proinflammatory and
proneoplastic environment, increasing the risk for CRC development (O'Keefe, 2016).
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The human GI tract harbors over 100 trillion microbial that span over 1,000
species (Ursell et al., 2014). Gut microbiome diversity and balance vary vastly by an
individual’s genetics, physiology, age, and diet (Hollister, Gao, & Versalovic, 2014). In
the past decade, the microbiome has been linked to multiple chronic diseases, including
GI disorders and cancers (Perry & Ying, 2016). In interventional studies, changes to the
diet led to changes in the microbiome in as little as 4 to 6 weeks. These shifts in the
microbiome, however, were reverted when subjects resumed their habitual diets (Xu &
Knight, 2015). Such observations suggest that the gut microbiota is dynamic in its
response to their environment.
Experimental models and clinical observations demonstrated the relationship
between fiber intake and CRC incidence via the microbiome. In experimental studies,
butyrate can induce apoptosis in colonocytes, regulate gene expression, and activate
gluconeogenesis (Bultman, 2013). These activities support the protective role of fiber
against CRC development. One of the first documentation of the potential link between
fiber and CRC risk stemmed from the observation of high fiber consumption in native
Africans and the low rate of CRC incidence (Burkitt, 1971). Conversely, interventional
studies that manipulated fiber and fat contents of the diet in native Africans and African
Americans reported increased secondary bile acids production and colonocytes
proliferation (David et al., 2014; O’Keefe et al., 2015). Subsequent studies reported
reduced risk when comparing high and low fiber intake. In one of the largest studies on
nutrition and cancer, over 428,000 participants across 10 European countries enrolled in
14
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the European Prospective Investigation into Cancer and Nutrition (EPIC) study. From
this cohort, Bingham et al. (2003) reported 25% reduced incidence risk in participants
with the highest fiber intake (95% CI [0.59, 0.95]; p < .001). Later, Murphy et al. (2012)
reported from an 11-year follow-up of the EPIC cohort and found a dose-response-like
effect by fiber intake, a 13% incidence risk reduction per 10 grams (g) average daily
consumption (Hazard Ratio [HR] = 0.87; 95% CI [0.79, 0.96]). Similarly, Aune et al.
(2011) reported from a meta-analysis of 25 prospective studies that every 10 grams per
day (g/d) of fiber intake was associated with approximately 10% decrease in CRC
incidence.
However, there was also reporting that fiber intake was inconsequential in CRC
development (Lin et al., 2005; Park et al., 2005; Schatzkin et al., 2007). This
inconsistency may be due to the various lengths of follow-up, heterogeneity in
methodologies, as well as uncaptured confounding factors. For example, in a prospective
case-control study, data on fiber intake collected via food diaries, rather than FFQs,
reached statistical significance (Dahm et al., 2010). Meanwhile, in a meta-analysis of 20
studies, case-control studies but not cohort studies showed an inverse association between
fiber intake and incident-CRC risk reduction (Ben et al., 2014).
As the population of CRC survivors grows in number and age, the role of dietary
fiber in secondary prevention demands further examination. Song et al. (2018) analyzed
data between 1980 to 2010 from the Nurses’ Health Study (Colditz, Manson, &
Hankinson, 1997) and the Health Professionals Follow Up Study (Rimm et al., 1991) to
15
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address fiber intake and mortality in CRC survivors. Self-administered FFQs from the
1,575 cohort participants with stages I, II, and III CRC provided pre- and postdiagnosis
fiber intake. For every five grams of daily fiber intake, they observed a 22% decrease risk
of CRC-specific mortality risk (HR = 0.78; 95% CI [0.65, 0.93]; p = .006). When looking
at the change in fiber intake postdiagnosis, every five-gram of incremental increase from
prediagnosis intake level was associated with an 18% reduction in CRC-specific
mortality risk (95% CI [0.72, 0.93]; p = .002). In the Prostate, Lung, Colorectal, and
Ovarian Cancer Screening trial, high fruits and vegetable intake was linked to a 25% risk
reduction of baseline adenomas detection. However, a similar intake in CRC survivors
did not lower recurrent adenomas detection (Kunzmann et al., 2015).
Based on current literature, the role of fiber in CRC risk reduction appears to be
two-fold: the absolute intake and the change in intake postdiagnosis. When examined
alone, neither factor demonstrated strong and consistent outcomes. This is likely because
the amount of fiber intake necessary to exert a definitive anticarcinogenic effect is above
40 g/d (Burkitt, 1971), far exceeds the current recommendation of 25 g/d by the DGA for
general health maintenance, and the 16 g/d of average intake in the United States (Hoy &
Goldman, 2014). For individuals with low fiber intake prediagnosis, increasing intake
may produce detectable health benefits. This study examined both the absolute and the
change in fiber intake in the MEC cohort in the hope of determining if these two factors
are associated with CRC-specific mortality in survivors.
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Dietary fat. The term total dietary fat describes the types of fatty acids
collectively including saturated fatty acids (SFA), trans fatty acids, monounsaturated fatty
acids (MUFA), and polyunsaturated fatty acids (PUFA). Perhaps due to its heterogeneity,
total dietary fat intake has not been consistent in its association with CRC incidence and
mortality risk.
In a retrospective case-control study of over 4,000 Canadians, total fat intake was
not associated with CRC incidence risk and neither was SFA (Odds Ratio [OR] = 1.00;
95% CI [0.79, 1.26]), MUFA (OR = 0.99; 95% CI [0.78, 1.26]), or PUFA (OR = 0.98;
95% CI [0.77, 1.23]); Sun et al., 2012). In a meta-analysis of 18 studies, no association
was found between fat consumption and incident-CRC risk: Total fat intake, RR = 1.00
(95% CI [0.90, 1.12]); SFA intake, RR = 0.97 (95% CI [0.86, 1.10]); MUFA intake, RR
= 1.08 (95% CI [0.92, 1.26]); and PUFA intake, RR = 0.99 (95% CI [0.93, 1.04]). These
findings highlight the effect of fats, if any, is modified by additional dietary, lifestyle, and
environmental factors.
However, data on intake of PUFA subtypes, primarily ω-3 PUFA such as αlinolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and
docosapentaenoic acid (DPA), supports the hypothesis that ω-3 PUFA may be protective
against incident-CRC development (Kato, Majumdar, Land, Barnholtz-Sloan, &
Severson, 2010; Norat et al., 2005; Song et al., 2018). Norat et al. (2005) reported from
the EPIC study that, during a 5-year follow-up period, fish consumption of approximately
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2.82 ounces per day reduced incident-CRC risk by 31% (HR = 0.69; 95% CI [0.54, 0.88])
compared to less than 0.35 ounce average daily consumption.
On the contrary, an analysis combining data from the Nurses’ Health Study and
Health Professionals Follow Up Study cohorts by Song et al. (2014) examined marine ω3 intake from over 123,000 American adults for 24 to 26 years reported neither marine ω3 nor ω-6 intake was associated with overall CRC risk. Rather, marine ω-3 intake was
associated with an increased risk in distal colon cancer in women (HR = 1.36; 95% CI
[1.03, 1.80]) and men (HR = 1.50; 95% CI [1.06, 2.12]). This finding was in line with the
observation that bacterial concentration is highest in the proximal colon, resulting in
stronger cellular protection from SCFA derived short-chain acids from fiber
fermentation, creating a gradient of diminishing defense in the distal colon (Yoshimoto et
al., 2013). In fact, despite the health benefits of fish and marine ω-3 consumption, several
species are prone to accumulate toxins such as mercury, dioxins, and polychlorinated
biphenyls (PCBs) that may contribute to cancer risk (Domingo, 2016; Paliwoda,
Newbigging, Wang, & Le, 2016). This theory is consistent with data from a Japanese
study that reported a U-curve associated with marine ω-3 intake and rectal cancer
(Sasazuki et al., 2011) as well as a study in Chinese women that found no association
between salt-water fish, fresh-water fish, and shellfish intake and incident-CRC risk but
increased risk from consuming seafood raised in industrial areas (Lee et al., 2009).
To date, few studies investigated, prospectively, the accumulative and the change
in marine ω-3 intake in CRC survivors (Song et al., 2017). CRC survivors from the
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Nurses’ Health Study and Health Professionals Follow Up Study were followed for a
median of 10.4 years. The highest postdiagnosis intake demonstrated a trend in CRCspecific mortality risk reduction (HR = 0.59; 95% CI [0.35, 1.01]; p for trend 0.03).
Survivors with the highest increase, > 0.15 g/d, experienced a 70% CRC-specific
mortality risk reduction, HR = 0.30 (95% CI [0.14, 0.64]) compared to minimal or no
change. In a smaller prospective study, 1,011 stage III CRC survivors were followed for a
median of 7 years (Van Blarigan et al., 2018). The highest quartile of marine ω-3 intake
was associated with a 32% risk reduction in recurrence (HR = 0.68, 95% CI [0.50, 0.94]).
In survivors whose tumors expressed high level of prostaglandin-endoperoxide synthase
2 (PTGS2), indicative of higher inflammation burden compared to those without,
recurrence-free survival by marine ω-3 intake was improved by 68% (HR = 0.32; 95% CI
[0.11, 0.95]). Data from these studies suggest that the effect of ω-3 PUFA intake may
differ in pre- and postdiagnosis. Furthermore, survivors with previously low ω-3 PUFA
intake or with late-stage and high inflammation CRC pathology may potentially receive
significant benefits in secondary prevention. Unfortunately, the insufficient amount of
evidence on CRC-specific mortality risk during survivorship leaves a notable void in
dietary recommendations for survivors.
Overview of the Manuscripts
The SEM describes the individual and environmental factors that influence health
outcomes. The following analyses address dietary intake and its implications on CRCspecific mortality risk in a racially diverse cohort. As reviewed, emerging evidence
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suggests that improved diet quality, increased fiber intake, and increased marine ω-3 fatty
acids may reduce mortality risks in survivors. As a result, the topic is examined from
three aspects: the predictiveness of postdiagnosis status of diet quality, dietary fiber
intake, dietary fat intake, and the change from prediagnosis levels on CRC-specific
mortality risk. The findings could provide future directions in interventional research and
public health education.
Manuscript 1
The health disparity between whites and non-white persons in the United States
encompasses a myriad of economic, psychosocial, and genetic factors. Among
modifiable risk factors, diet quality is inversely correlated with CRC incidence and
mortality rates. However, it is unclear whether a change in dietary quality following CRC
diagnosis could produce a similar health impact. This analysis examined the potential
association between diet quality and the likelihood of CRC-specific mortality risk in a
racially diverse cohort.
Research question.
Do postdiagnosis HEI-2010 score and its change from prediagnosis predict CRCspecific mortality in CRC survivors in the MEC?
My hypothesis is that increased HEI-2010 postdiagnosis is associated with a
reduction in CRC-specific mortality risk in survivors when compared to a decrease or no
change in score from prediagnosis level.
Nature of the study.
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This quantitative study is a secondary data analysis of prospectively collected
dietary data from the MEC to examine the relationship between diet, cancers, and chronic
diseases (University of Hawaii, 2019). The FFQ used in dietary data collection was
culturally tailored and validated for use with African Americans, Japanese Americans,
Latinos, Native Hawaiians, and non-Hispanic whites. CRC cases and deaths in the cohort
were identified via established linkage between the MEC database and state-level cancer
registries and death records. Dietary intake of CRC survivors at baseline and follow-up
was calculated into HEI-2010 scores and then quartiles. The first part of the study will
estimate CRC-specific mortality risk by comparing postdiagnosis score quartile. The
second part of the study will pair participants’ pre and postdiagnosis quartiles to reflect
change in diet quality. The 1st and 2nd quartiles are defined as low quality whereas the 3rd
and 4th quartiles are defined as high quality, thus creating four categories for diet quality
change: low/low (referent), low/high, high/low, and high/high. The quartiles are then
entered into a Cox proportional hazard regression model to compare the different levels
of change and compute hazard ratios (HRs) and 95% confidence intervals (CIs)
corresponding to the mortality risk associated with each level of change in diet quality.
Study procedures.
The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000). Consent to participate in the MEC
surveys were collected at the time of cohort entry by the University of Hawaii (UH) and
the University of Southern California (USC). The analysis will utilize readily available
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data with no supplemental questionnaires, biological samples, or personal contact with
the participant. Upon approval from Walden University’s Institutional Review Board
(IRB), UH will create a limited data set for download via password-protected remote
access. Statistical analysis and results will be stored as encrypted files on the author’s
Laureate Education cloud-based OneDrive server for the duration of this study. The
analysis will be performed at the author’s secured home office in Seattle, Washington.
This study utilizes the established linkage between the MEC’s database and the
Surveillance, Epidemiology, and End Results Program tumor (SEER) registries in
California and Hawaii for CRC case ascertainment. For CRC-specific mortality, the MEC
cohort database is linked to the States’ death certificate records and the National Death
Index. All personal identifiable information (PII) is masked by the UH following data
cleaning and linkage to cancer registries and death records. The main exclusion criterion
for this study is the history or presence of CRC at enrollment, as identified from
responses in the baseline questionnaire or the tumor registries. Furthermore, participants
who identified outside of the major racial groups of African American, Native Hawaiian,
Japanese American, Latino, and non-Hispanic white are excluded. Finally, participants
who reported implausible dietary intakes would be excluded.
Variables.
The dependent variable is CRC-death. Predictor in Cox regression (dietary
exposure) is the postdiagnosis HEI-2010 score and the change in scores from
(prediagnosis level, calculated into quartiles.
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Descriptive statistics: (a) Age at cohort entry, continuous variable; (b) Age at
diagnosis, continuous variable; (c) Race (non-Hispanic white, African American, Native
Hawaiian, Japanese American, Latino), categorical variable; (d) Sex, categorical variable;
(e) Body mass index, continuous variable; (f) Family history of CRC; categorical
variable; (g) History of intestinal polyps; categorical variable; (h) NSAIDs use,
categorical variable; (i) Physical activity (hours/day), continuous variable; (j) Smoking
status, categorical variable; (k) Alcohol intake (grams ethanol/day), continuous variable;
(l) Total energy intake (calories/day), continuous variable; (m) Education level, interval
variable.
Sources of data.
The study utilizes data from the MEC in conjunction with established linkage to
publicly available administrative data from the SEER registries, the death certificate files
from the states of California and Hawaii, and the National Death Index. CRC case
ascertainment will be based on the following International Statistical Classification of
Oncology, (3rd ed.; ICD-O-3) codes (National Cancer Institute [NCI], 2016) to identify
cohort participants with CRC diagnosis:
a. Malignant neoplasm of the cecum (C18.0)
b. Malignant neoplasm of the appendix (C18.1)
c. Malignant neoplasm of the ascending colon; right colon (C18.2)
d. Malignant neoplasm of the hepatic flexure of the colon (C18.3)
e. Malignant neoplasm of the transverse colon (C18.4)
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f. Malignant neoplasm of the splenic flexure of the colon (C18.5)
g. Malignant neoplasm of descending colon; left colon (C18.6)
h. Malignant neoplasm of the sigmoid colon (C18.7)
i. Malignant neoplasm of overlapping lesion of the colon (C18.8)
j. Malignant neoplasm of the colon, NOS (C18.9)
k. Malignant neoplasm of the rectosigmoid junction (C19.9)
l. Malignant neoplasm of the rectum, NOS (C20.9)
Power analysis.
The MEC reported 6,451 cases of invasive CRC between baseline and December
31, 2014. Of this, 1,166 participants provided postdiagnosis dietary data. Power analysis
by the Statistical Package for the Social Sciences (SPSS) version 25 for Cox proportional
hazard regression using a two-tailed alpha of 0.05, 0.25 effect size, and 55% survival rate
yielded 0.8844.
Manuscript 2
Dietary fiber intake has been inversely associated with decreased incidence and
mortality rates in CRC. However, it is less conclusive if dietary fiber intake postdiagnosis
is associated with long-term survival outcomes. Meanwhile, postdiagnosis dietary fiber
intake can be influenced by cultural food preferences as well as GI tolerance. This
analysis examines the relationship between dietary fiber intake postdiagnosis and CRCspecific mortality in a culturally diverse cohort.
Research question.
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Does dietary fiber intake postdiagnosis, and its change from prediagnostic level
predict CRC-specific mortality risk in survivors in the MEC?
I hypothesized that an increase in dietary fiber intake postdiagnosis is associated
with reductions in the risk of CRC-specific mortality compared to a decrease or no
change in intake.
Nature of the study.
This quantitative study was a secondary data analysis of prospectively collected
dietary data from the MEC to examine the relationship between diet, cancers, and chronic
diseases (University of Hawaii, 2019). The FFQ used in dietary data collection was
culturally tailored and validated for use with African Americans, Japanese Americans,
Latinos, Native Hawaiians, and non-Hispanic whites. CRC cases and deaths in the cohort
were identified via established linkage between the MEC database and state-level cancer
registries and death records. Postdiagnosis fiber intake is calculated from FFQ responses
in the follow-up survey. The change in intake will be calculated by subtracting
prediagnosis intake from postdiagnosis intake and grouped as followed: ≥ 5 g/d decrease,
< 5 g/d decrease, < 5 g/d increase, and ≥ 5 g/d increase. Cox regression will be used to
estimate the corresponding mortality risk, using the least increase group, ≥ 5 g/day
decrease, as the referent. The model computes the hazard ratios (HRs) and 95%
confidence intervals (CIs)for each level of change, indicating their associated CRCspecific mortality risk.
Study procedures.
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The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000). Consent to participate in the MEC
surveys were collected at the time of cohort entry by the University of Hawaii (UH) and
the University of Southern California (USC). The analysis will utilize readily available
data with no supplemental questionnaires, biological samples, or personal contact with
the participant. Upon approval from Walden University’s IRB, UH will create a limited
data set for download via password-protected remote access. Statistical analysis and
results will be stored as encrypted files on the author’s Laureate Education cloud-based
OneDrive server for the duration of this study. The analysis will be performed at the
author’s secured home office in Seattle, Washington.
This study utilizes the established linkage between the MEC’s database and the
SEER registries in California and Hawaii for CRC case ascertainment. For CRC-specific
mortality, the MEC cohort database is linked to the States’ death certificate records and
the National Death Index. All personal identifiable information (PII) is masked by the
UH following data cleaning and linkage to cancer registries and death records. The main
exclusion criterion for this study is the history or presence of CRC at enrollment, as
identified from responses in the baseline questionnaire or the tumor registries.
Furthermore, participants who identified outside of the major racial groups of African
American, Native Hawaiian, Japanese American, Latino, and non-Hispanic white are
excluded. Finally, participants with implausible responses regarding dietary intakes are
excluded.
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Variables.
The dependent variable is CRC-death. Predictors for CRC-specific mortality in
Cox regression model: (a) Dietary fiber (g/d), continuous variable; and (b) Change in
dietary fiber intake (g/d), interval variable. Change in intake is calculated by subtracting
the participant’s prediagnosis intake from postdiagnosis intake.
Descriptive statistics: (a) Age at cohort entry, continuous variable; (b) Age at
diagnosis, continuous variable; (c) Race (non-Hispanic white, African American, Native
Hawaiian, Japanese American, Latino), categorical variable; (d) Sex, categorical variable;
(e) Body mass index, continuous variable; (f) Family history of CRC; categorical
variable; (g) History of intestinal polyps; categorical variable; (h) NSAIDs use,
categorical variable; (i) Physical activity (hours/day), continuous variable; (j) Smoking
status, categorical variable; (k) Alcohol intake (grams ethanol/day), continuous variable;
(l) Total energy intake (calories/day), continuous variable; (m) Education level, interval
variable.
Sources of data.
The study utilizes data from the MEC study in conjunction with established
linkage to publicly available administrative data from the SEER registries, the death
certificate files from the states of California and Hawaii, and the National Death Index.
CRC case ascertainment will be based on the following ICD-O-3 codes to identify cohort
participants with CRC diagnosis:
a. Malignant neoplasm of the cecum (C18.0)
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b. Malignant neoplasm of the appendix (C18.1)
c. Malignant neoplasm of the ascending colon; right colon (C18.2)
d. Malignant neoplasm of the hepatic flexure of the colon (C18.3)
e. Malignant neoplasm of the transverse colon (C18.4)
f. Malignant neoplasm of the splenic flexure of the colon (C18.5)
g. Malignant neoplasm of descending colon; left colon (C18.6)
h. Malignant neoplasm of the sigmoid colon (C18.7)
i. Malignant neoplasm of overlapping lesion of the colon (C18.8)
j. Malignant neoplasm of the colon, NOS (C18.9)
k. Malignant neoplasm of the rectosigmoid junction (C19.9)
l. Malignant neoplasm of the rectum, NOS (C20.9)

Power analysis.
The MEC reported 6,451 cases of invasive CRC between baseline and December
31, 2014. Of this, 1,166 participants provided postdiagnosis dietary data. Power analysis
by the Statistical Package for the Social Sciences (SPSS) version 25 for Cox proportional
hazard regression using a two-tailed alpha of 0.05, 0.25 effect size, and 55% survival rate
yielded 0.8844.
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Manuscript 3
The Western diet— a diet pattern high in fat, sugar, and processed food—has
been linked to varying degrees of risk in CRC development. However, dietary fat
subtypes were observed to differ in their health impacts. To date, little is known if
altering one’s dietary fat intake postdiagnosis could be beneficial during CRC
survivorship. This analysis examines whether postdiagnosis intake of dietary fat, fat from
fish and shellfish, and their changes from prediagnosis levels are associated with CRCspecific mortality.
Research question.
Do changes in intake of dietary fat from fish and shellfish postdiagnosis predict
CRC-specific mortality in African American, Japanese American, Latino, and nonHispanic white CRC survivors in the MEC?
I hypothesized that an increase in total dietary fat intake would increase mortality
risk, whereas an increase in fat from fish and shellfish would reduce mortality risk in
CRC survivors compared to a decrease or no change postdiagnosis.
Nature of the study.
This quantitative study was a secondary data analysis of prospectively collected
dietary data from the MEC to examine the relationship between diet, cancers, and chronic
diseases (University of Hawaii, 2019). The FFQ used in dietary data collection was
culturally tailored and validated for use with African Americans, Japanese Americans,
Latinos, Native Hawaiians, and non-Hispanic whites. CRC cases and deaths in the cohort
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were identified via established linkage between the MEC database and state-level cancer
registries and death records. The level of total fat as percent of energy and fat from fish
and shellfish intake were assessed from participants’ follow-up FFQ responses. The
change in intake will be calculated by subtracting prediagnosis intake from postdiagnosis
level and grouped into quartiles: ≥ 5% decrease, < 5% decrease, < 5% increase, and ≥ 5%
increase for total fat and ≥ 0.25 g decrease, < 0.25 g decrease, < 0.25 g increase, and ≥
0.25 g increase for fat from fish and shellfish. Cox regression models will be used to
estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the mortality risk by
intake quartiles.
Study procedures.
The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000). Consent to participate in the MEC
surveys were collected at the time of cohort entry by the University of Hawaii (UH) and
the University of Southern California (USC). The analysis will utilize readily available
data with no supplemental questionnaires, biological samples, or personal contact with
the participant. Upon approval from Walden University’s IRB, UH will create a limited
data set for download via password-protected remote access. Statistical analysis and
results will be stored as encrypted files on the author’s Laureate Education cloud-based
OneDrive server for the duration of this study. The analysis will be performed at the
author’s secured home office in Seattle, Washington.
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This study utilizes the established linkage between the MEC’s database and the
SEER registries in California and Hawaii for CRC case ascertainment. For CRC-specific
mortality, the MEC cohort database is linked to the States’ death certificate records and
the National Death Index. All personal identifiable information (PII) is masked by the
UH following data cleaning and linkage to cancer registries and death records. The main
exclusion criterion for this study is the history or presence of CRC at enrollment, as
identified from responses in the baseline questionnaire or the tumor registries.
Furthermore, participants who identified outside of the major racial groups of African
American, Native Hawaiian, Japanese American, Latino, and non-Hispanic white are
excluded. Finally, participants who reported implausible dietary intakes are excluded.
Variables.
The dependent variable is CRC-death. Predictors for CRC development in Cox
regression model, continuous variables: (a) Total dietary fat, as a percentage of total
energy intake; (b) fat from fish and shellfish; (c) change in total dietary fat intake; (d)
change in fat intake from fish and shellfish (subtracting prediagnosis level from
postdiagnosis level).
Descriptive statistics: (a) Age at cohort entry, continuous variable; (b) Age at
diagnosis, continuous variable; (c) Race (non-Hispanic white, African American, Native
Hawaiian, Japanese American, Latino), categorical variable; (d) Sex, categorical variable;
(e) Body mass index, continuous variable; (f) Family history of CRC; categorical
variable; (g) History of intestinal polyps; categorical variable; (h) NSAIDs use,
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categorical variable; (i) Physical activity (hours/day), continuous variable; (j) Smoking
status, categorical variable; (k) Alcohol intake (grams ethanol/day), continuous variable;
(l) Total energy intake (calories/day), continuous variable; (m) Education level, interval
variable.
Sources of data.
The study utilizes data from the MEC study in conjunction with established
linkage to publicly available administrative data from the SEER registries, the death
certificate files from the states of California and Hawaii, and the National Death Index.
CRC case ascertainment will be based on the following ICD-O-3 codes to identify cohort
participants with CRC diagnosis:
a. Malignant neoplasm of the cecum (C18.0)
b. Malignant neoplasm of the appendix (C18.1)
c. Malignant neoplasm of the ascending colon; right colon (C18.2)
d. Malignant neoplasm of the hepatic flexure of the colon (C18.3)
e. Malignant neoplasm of the transverse colon (C18.4)
f. Malignant neoplasm of the splenic flexure of the colon (C18.5)
g. Malignant neoplasm of descending colon; left colon (C18.6)
h. Malignant neoplasm of the sigmoid colon (C18.7)
i. Malignant neoplasm of overlapping lesion of the colon (C18.8)
j. Malignant neoplasm of the colon, NOS (C18.9)
k. Malignant neoplasm of the rectosigmoid junction (C19.9)
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l. Malignant neoplasm of the rectum, NOS (C20.9)
Power analysis.
The MEC reported 6,451 cases of invasive CRC between baseline and December
31, 2014. Of this, 1,166 participants provided postdiagnosis dietary data. Power analysis
by the Statistical Package for the Social Sciences (SPSS) version 25 for Cox proportional
hazard regression using a two-tailed alpha of 0.05, 0.25 effect size, and 55% survival rate
yielded 0.8844.
Significance
The number of CRC survivors is increasing due to younger onset, earlier
detection, and improved treatment. However, the volume of evidence in recurrent-CRC
and mortality is limited. Additionally, much of the data on nutrition and CRC recurrence
was extrapolated from cohorts with high participation by non-Hispanic Whites, which
does not reflect the demographics of CRC patients in the United States. The lack of
evidence in secondary prevention results in dietary recommendations that are essentially
identical for cancer-free individuals and survivors, failing to harness the interdisciplinary
experience in established risk factors. This disconnect is amplified as survivor care needs
reach public health magnitude. Meanwhile this data gap creates an opportunity for
epidemiologists to explore if and how diets may influence long-term health outcomes.
The proposed study initiates some of the first steps in identifying dietary factors that may
enhance CRC survivorship, thus an innovation toward social change.
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Summary
CRC is among the top five malignancies domestically and globally. As
survivorship grows in length, concerns for recurrence are common. This study examines
the relationship between diet quality, fiber, and fat consumption and CRC-specific
mortality risk in survivors in the MEC. The research questions surround a central theme
of pre- and postdiagnosis changes in dietary intakes and their association with recurrenceassociated mortality. The analyses aim to extend existing knowledge on the role of diet in
secondary prevention. As such, the findings may contribute to the understanding of the
dietary choices of survivors and generate evidence toward meaningful survivorships.
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Abstract
Strong evidence exists on the relationship between diet and colorectal cancer (CRC)
concerning primary prevention. As the number of CRC survivors grows, there is an
emerging gap in nutrition knowledge focused on the secondary prevention of CRC. The
objective of this study was to examine the risk of CRC-specific mortality based on postCRC diet quality as measured by the Healthy Eating Index-2010 (HEI-2010. The
Multiethnic Cohort Study (MEC) is a prospective cohort established to explore the
relationship between diet and chronic diseases in a diverse population. Dietary intakes
were assessed via a culturally validated Food Frequency Questionnaire (FFQ). Nine
hundred eighty-nine CRC survivors were included in this post-hoc analysis. Cox
proportional hazard regression was used to estimate CRC-specific mortality risk
associated with postdiagnosis HEI-2010 scores and the change in scores from baseline.
Median follow up was 18.4 years, with an average of 5.6 years between CRC diagnosis
and postdiagnosis FFQ. Survival analysis of postdiagnosis HEI-2010 scores showed no
impact on CRC-specific mortality risk (4th versus 1st quartile HR = 0.72, 95% CI [0.36,
1.75], p = .572). However, participants who increased their scores from prediagnosis
level experienced an increased CRC-specific mortality risk (low/high versus low/low HR
= 2.00, 95% CI [1.02, 3.92], p = .044). In this sample, the HEI-2010, which was designed
to assess diet quality in the general population, may not be aligned with the dietary needs
to reduce CRC-specific mortality risk in survivors. Consequently, CRC survivors may
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require tailored instruments or study designs to generate applicable dietary
recommendations.
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Background
Colorectal cancer (CRC) is the third leading cancer for men and women, and the
second most common cause of cancer deaths in the United States (American Cancer
Society [ACS], 2020a). In 2020, the expected number of incident colon cancer will reach
104,610 cases while rectal cancer will reach 43,340 (Siegel et al., 2020). In recent years,
screening efforts and treatment advancements have led to improved survival. When
combining all stages of CRC at diagnosis, the 5-year survival rates of colon and rectal
cancers are 64% and 67%, respectively (ACS, 2020a). As a result, CRC survivors are a
growing population of over one million Americans. However, compared to primary
prevention, less is understood about secondary prevention in CRC. Moreover, most
studies to date investigated non-Hispanic White cohort participants. Considering that
African Americans and Japanese Americans experience increased incidence risks (ACS,
2020a; Jin, Pinheiro, Xu, & Amei, 2016), research in a racially diverse population is
needed.
Diet has consistently demonstrated an association with incidence and mortality
risks in first-time CRC patients. It is a personal level factor in the socioecological model
of health and frequently one of the first line targets in cancer survivorship. However, its
relationship with recurrence-free survival is inconclusive (Fung et al., 2014; Meyerhardt,
Niedzwiecki, & Hollis, 2007; Ratjen et al., 2017; Vrieling & Kampman, 2010).
Historically, nutrition research focuses on single-nutrients and their relationships with
diseases. In the past decade, there is increasing recognition of the synergistic effect of
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foods, leading to the development of dietary indices as a tool to quantify dietary patterns
and quality. In practice, an individual’s food intake is quantified into a score
corresponding to the index’s scoring system (Kant, 2004).
The U.S. Department of Agriculture (USDA) debuted the Healthy Eating Index
(HEI) in 1995 to measure adherence to the Dietary Guideline for Americans (DGA)
(Kennedy, Ohls, Carlson, & Fleming 1995). It is a priori index based on scientific
evidence and updated every 5 years along with new DGA releases. The HEI-2010 was a
collaborative update by the USDA and the U.S. Department of Health and Human
Services (Guinther et al., 2013). It contains 12 components that emphasize nutritional
adequacy and moderation (National Cancer Institute [NCI], 2018). The HEI-2010
includes nine adequacy categories (total vegetables, total fruits, whole fruits, greens and
beans, whole grains, dairy, total protein, seafood and plant protein, and fatty acids) and
three moderation components (sodium, refined grains, and empty calories; NCI, 2019).
The higher the index score, the higher the conformance to the DGA (Guinther, 2014).
High-quality diets have shown promising results in incident-CRC risk reduction.
Schwingshackl, Bogensberger, and Hoffmann (2018) conducted a large-scale metaanalysis in which the pooled analysis of 6 cohorts showed a 23% relative risk reduction
in combined incidence and mortality risk associated with high HEI scores. In the National
Health Institute-American Association of Retired Persons (NIH-AARP) cohort, Reedy et
al. (2008) found a 20% and 28% lower incidence risk in women and men, respectively,
associated with high HEI scores. Meanwhile, Park, Boushey, Wilkens, Haiman, &
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Marchand (2017) reported that high HEI-2010 scores at baseline were inversely linked to
CRC incidence risk in the MEC. Men and women who scored in the top quintile
experienced 31% and 28% reduced incidences, respectively.
Similar dietary effects may be at play among cancer survivors. Karavasiloglou et
al. (2019) detected a 42% recurrence risk reduction among 522 cancer survivors who
scored in the top 40% of the HEI-2010. Specific to CRC, Meyerhardt et al. (2007)
reported a 185% increase in recurrent cancer risk among 1,009 CRC survivors who
scored in the highest quintile of a Western dietary pattern. Additionally, in a metaanalysis by Schwedhelm et al. (2017), a prudent dietary pattern postdiagnosis showed a
23% reduction, while a Western dietary pattern was associated with a 51% increase in
recurrent-CRC risk. However, the volume of evidence specific to CRC survivors remains
low and may or may not be extrapolated from analyses that combined multiple cancer
types.
The objective of this analysis is whether changes in diet quality, as assessed by
the HEI-2010, affect the CRC-specific mortality risk in survivors in the Multiethnic
Cohort Study. (MEC) It is hypothesized that improvement in diet quality postdiagnosis is
associated with a reduction in CRC-specific mortality risk.
Methodology
Study Population
The MEC is a prospective cohort study established to investigate the association
of lifestyle and genetic factors in the development of cancer and chronic diseases
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(Kolonel et al., 2000). The sampling frames utilized publicly available information from
driver’s license files, voter registration records, and Medicare enrollment to achieve a
racially and socioeconomically diverse participant pool in Los Angeles County and the
state of Hawaii from 1993 to 1996. The study’s design and data collection method have
been previously published (Kolonel et al., 2000). Surveys were mailed to eligible
individuals with up to three attempts. MEC participation was initiated when residents
completed a self-administered questionnaire that included baseline demographic
information, medical history, and a detailed dietary assessment. Over 215,000
participants were enrolled, who self-identified primarily with the following
race/ethnicities: African American, Native Hawaiian, Japanese American, Latino, and
non-Hispanic White. The institutional review boards of the University of Hawaii and the
University of Southern California approved the MEC study protocol, and all participants
provided written informed consent. In addition, this analysis was approved by Walden
University’s institutional review board (01-08-20-0641131).
Healthy Eating Index Score Assessment and Calculation
The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000; Stram et al., 2000). Upon entry to
the cohort, participants completed a 26-page baseline questionnaire. As part of the
survey, a culturally tailored quantitative Food Frequency Questionnaire (FFQ) with more
than 180 items was included (Stram et al., 2000). The FFQ was validated and calibrated
in ethnic-sex matched groups through three repeated 24-hour diet recalls. The
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questionnaire assessed habitual intake over the previous 12 months. Detailed instructions
in English and Spanish were provided along with images of portion sizes referenced in
the multiple-choice responses. Prediagnosis diet quality was based on baseline FFQ,
while the follow-up FFQ assessed postdiagnosis diet quality. Average daily nutrient
intakes were calculated using the food composition tables developed and maintained at
the University of Hawaii Cancer Center specifically for the use in the MEC (Murphy,
2002). The HEI score was calculated using MEC participants’ FFQ responses (Liese et
al., 2015).
Case Ascertainment
This study utilizes the established linkage between the MEC study dataset and the
Surveillance, Epidemiology, and End Results Program (SEER) tumor registries in
California and Hawaii for the identification of CRC cases (Kolonel et al., 2000). The
main exclusion is the history or prevalence CRC at baseline, as identified from responses
in the baseline questionnaire or the tumor registries. Cases in this study only included
invasive colonic, rectal, or mixed adenocarcinomas. Classification of anatomic sites was
based on the International Classification of Disease for Oncology, third edition (ICD-O3) codes under colon excluding rectum and rectum and rectosigmoid junction: C180C189, C199, C209, and C260. For CRC-specific death ascertainment, public records
from the States’ death certificate records and the National Death Index were accessed
through December 31, 2014. Furthermore, participants who identified outside of the
major race/ethnicity groups of African American, Native Hawaiian, Japanese American,
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Latino, and non-Hispanic White are excluded. Finally, participants with implausible
responses regarding dietary intakes are also excluded.
Statistical Analysis
Between baseline and December 31, 2014, there were 6,451 cases of invasive
CRC reported in the cohort in which postdiagnosis dietary data was available for 1,166 of
them. After eliminating implausible dietary intakes— energy over 5,000 kcal/d and
dietary fiber over 100 g/d for (N = 25) and excluding participants who returned their
follow-up questionnaire within 12 months of incident-CRC diagnosis (n = 152), the final
sample size was 989. Missing data were handled with median replacement. Post-hoc
power analysis for Cox proportional hazard regression used a two-tailed alpha of 0.05,
0.25 effect size, and a 55% 10-year survival rate, which yielded a statistical power of
0.8285. For prediagnosis diet quality, person-time was calculated from the date of cohort
entry to the index date. For postdiagnosis diet quality, the date of CRC diagnosis to the
first instance of death, censoring, or end of study was used to calculate the person-time.
Descriptive statistics were used to demonstrate baseline characteristics. Cox
proportional hazards regression modeling was used to examine CRC-specific mortality
risks for both postdiagnosis HEI-2010 scores and the change in scores from prediagnosis
intake. Hazard ratios and 95% confidence intervals (CI) estimations were calculated.
Univariate analysis was performed to assess model fit before adjustments with covariates,
which included demographic characteristics (sex, race, and education level),
clinicopathological factors (age at diagnosis, history of polyps, and family history of
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CRC), lifestyle factors (body mass index (BMI), physical activity, smoking status, and
the use of non-steroid anti-inflammatory drug (NSAID) at follow-up), and dietary factors
(total energy and alcohol consumption at follow-up). The participant’s affirmative
response defined the history of intestinal polyps. Family history of CRC was defined by
participants’ baseline response of the disease in mother, father, or siblings. BMI was
calculated from self-reported height and weight at follow-up. Physical activity was coded
as none, up to 150 min/day, or more than 150 min/day of moderate to vigorous activities.
Cigarette smoking statuses were never smoked, past smoker, and current smoker.
Education levels were grouped as less than high school, high school, some college and
college, and post-graduate. Finally, NSAIDs use was based on self-reported use at
follow-up as never used, past, or current usage of at least twice a week for longer than
one month. Missing data were replaced with median values. To analyze the change in
HEI-2010 score and mortality risk, the prediagnosis and postdiagnosis scores were
calculated into quartiles where the 1st and 2nd quartiles were classified as low and 3rd and
4th quartiles were classified as high. The quartiles were then paired as low/low, low/high,
high/low, and high/high to reflect the participant’s change in score. Likelihood ratio test
confirmed model fit. Regression analysis was applied to test for interactions and
collinearity. All analyses were performed in SPSS version 25.
Results
The sample was composed of 55.4% male. The racial/ethnic distribution was as
followed: 42.6% Japanese Americans, 22.0% non-Hispanic whites, 14.5% Latinos,
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13.5% African Americans, and 7.4% Native Hawaiians. Among the 989 CRC survivors,
718 cases were colon cancer, 263 cases were rectal cancer, and 8 cases were mixed
cancer. The mean follow-up was 18.6 years. Table 1 presents the participants’
characteristics at baseline and follow-up by HEI-2010 quartiles. The average age at
cohort entry was 62.5 years old (SD = 8.0), the age at incident-CRC diagnosis was 68.4
years old (SD = 8.2), and the age at death was 81.9 years old (SD = 7.5). On average,
there were 5.6 years (SD = 3.0) between diagnosis and follow-up FFQ. By the end of the
study period, there were 261 deaths with 49 cases attributed to CRC (18.8%) (Table 2).
The CRC-specific mortality rate was 22.1% for HEI scores below the median and 16.1%
for scores above the median.
The median baseline HEI-2010 score was 68 (SD = 11). Quartile medians were
53, 64, 71, and 80. Postdiagnosis, there was a small increase of HEI scores across all
quartiles. The median score was 70 (SD = 11), with interquartile medians 57, 67, 73, and
82. Compared to baseline, participants exhibited a change in score from a reduction of 34
points to an increase of 43 points. The quartile medians for change in score were -10, -1,
6, and 15 (data not shown). Participants with the most increase in scores tend to be
younger at diagnosis compared to those who decreased in scores (66.7 versus 71.0 years
old).
The impact of the postdiagnosis score and the change in score on CRC-mortality
were examined in univariate regression models, in which neither model produced
statistical significance (data not shown). In the adjusted models, the postdiagnosis score
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was not statistically significant. However, a change in score was statistically significant.
Table 3 shows the low/high pairing was a significant predictor, HR = 2.00 (95% CI [1.02,
3.92], p = .044), suggesting that participants whose scores increased from below to above
the median experienced a higher odds of CRC-specific mortality in comparison to those
whose scores remained below the median. The high/high pairing was not entered into the
regression model due to linear dependencies with the low/high and high/low groupings.
For covariates, older age at diagnosis was associated with higher odds of mortality (HR =
1.05, 95% CI [1.02, 1.09], p = .004). Participants who reported a history of intestinal
polyps showed lower odds of mortality (HR = 0.50, 95% CI [0.30, 0.81], p = .005). Their
significance is consistent with chi-square and point-biserial correlation tests (data not
shown).
Discussion
This study examined the impact of the HEI-2010 score postdiagnosis in the
context of CRC secondary prevention. Although the rate of CRC-specific mortality trends
down in the upper quartiles, the hazard ratio did not differ statistically across quartile.
Interestingly, participants who increased their scores from the lower to upper quartiles
experienced increased odds in CRC-specific mortality risk. The finding suggests that an
effort to improve diet quality, as measured by the HEI-2010 may not reap the health
benefits that are typically expected.
Previous studies have shown that diets high in whole grains, fruits, and
vegetables, low in fat and added sugar were associated with lower mortality risk among
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CRC survivors. Guinter et al. (2018) reported from the Cancer Prevention Study-II
Nutrition Cohort that postdiagnosis increase in the DASH and prudent dietary pattern
scores were associated with lower CRC-specific mortality. In another study,
Karavasiloglou et al. (2019) analyzed self-reported lifestyle data from cancer survivors in
NHANES III. They found that HEI-2010 scores above 69.3 were associated with reduced
all-cause mortality by 42%. Meanwhile, Meyerhardt et al. (2007) reported that
postdiagnosis scores on a Western dietary pattern scale in stage III CRC survivors were
positively associated with recurrence. In comparison, the prudent dietary pattern scale
correlated with neither recurrence nor all-cause mortality. Such findings point to the
possible benefits of healthful diets in lowering CRC recurrence and mortality during
survivorship.
In contrast, our findings revealed a potential risk in CRC-specific mortality
associated with an increase that crossed the sample’s median HEI-2010 score, 70. It is
worth noting that our survival analysis did not allude to any causational direction. As
seen in the socioecological model of health, behavioral factors at the personal level are
more controllable than that of organizational and societal levels. A possible explanation
is that survivors who perceived higher mortality risk made a more considerable effort to
improve their diets. Also, the observed trend of greater score increase among younger age
at diagnosis could have implications on the long length of the follow-up period. As the
HEI score is calculated from multiple dietary components, it is difficult to speculate the
drivers in our results without analyzing each of the components. For example, an
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individual may receive one less point for five components or 0 points for a single
component and arrives at the same total score. However, each component's health effects
may not be equal, especially post CRC, where the physiology, immune functions, and
microbiome of the GI tract may be altered.
Additionally, the cohort populations in previous studies were composed of mainly
Caucasians, up to 97%. This factor might influence incident-CRC risk, and mortality
rates since the MEC participants' racial background may entail health determinants that
could be challenging to quantify in epidemiological settings. Also, differences in study
designs such as geographical regions and available clinical covariates may contribute to
differences in findings. Finally, CRC treatment often results in critical disturbances to the
GI system. Thus, survivors are a highly heterogeneous group with varying dietary
tolerance. The ACS recommends a high protein and low fiber during treatment recovery
to accommodate common symptoms like cramps, bloating, flatulence, diarrhea, and more
(ACS, 2020-b). As such, it contradicts that of a conventional healthy diet. In cases where
surgical resection necessitates, the remaining ileum or colon can take up to 5 years to
adapt and compensate for lost functions. It is not clear when and how CRC survivors' diet
transitions from the recovery phase to long-term health maintenance, which is likely
individually tailored.
Strengths and Limitations
This study has several limitations. First, the cohort was established in Los
Angeles County and the State of Hawaii. Therefore, the socio-environmental factors may
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have both direct and indirect influences on health outcomes that cannot be generalized
nationally. Second, clinical data lacked length and regimen of CRC treatment, which
could have implications on the recovery and dietary needs. Third, demographic data such
as social support and dietary acculturation levels were not available, both of which have
been known to affect dietary behaviors. The strengths of this study included the large
cohort sample size, the diversity of the participants, the use of a culturally validated FFQ,
and the length of the follow-up period. To the best of our knowledge, this is the first
study on this topic in a racially diverse prospective cohort.
Conclusion
In summary, the dietary transition from CRC recovery to long-term survivorship
is full of unique challenges. In this sample of diverse survivors, an improvement in diet
quality as measured by the HEI-2010, specifically from below to above the median score
of 70 points, was associated with increased odds of CRC-specific mortality compared to
remaining below the median score. Considering that the HEI was validated in generally
healthy Americans, it may or may not be the ideal index to evaluate diet quality in CRC
survivors. Alternately, the ACS dietary score, DASH score, and prudent dietary pattern
scale have shown an inverse relationship with CRC recurrence and mortality risk. In
practice, clinicians and public health educators supporting CRC survivors may consider
additional health determinants relevant to the individual when devising a holistic lifestyle
plan toward disease-free living. Future cohort studies may recruit participants from
multiple geographies representative of national regions. Furthermore, data collection,
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including both the selection of instruments and questionnaires that are validated in the
CRC survivor population may be of interest.
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Tables and Figures
Table 1
Baseline and Follow-up Characteristics of Colorectal Cancer Survivors in the Multiethnic Cohort Study by Quartiles
of the Healthy Eating Index-2010 Score
Baseline (prediagnosis)
Quartile median

Follow-up (postdiagnosis)

N

Q1

Q2

Q3

Q4

N

Q1

Q2

Q3

Q4

Score, median

989

53

64

71

80

989

57

67

73

82

Cases

989

285

272

299

285

989

284

256

315

286

Men %

548

67.4

62.1

52.2

36.8

548

66.9

59.8

52.7

39.5

Women %

441

32.6

37.9

47.8

63.2

441

33.1

40.2

47.3

60.5

White

218

17.5

21.0

20.4

27.4

218

21.8

20.3

19.0

25.2

African American

134

11.9

11.4

15.7

18.2

134

15.5

12.5

14.6

14.7

Native Hawaiian

73

11.6

7.7

4.0

5.3

73

8.8

6.3

8.9

4.2

Japanese American

421

40.4

42.3

47.5

39.9

421

34.5

43.4

45.4

46.2

Latino

143

18.6

17.6

12.4

9.8

143

19.4

17.6

12.0

9.8

989

27.3

26.8

26.7

25.8

989

26.6

26.4

26.6

25.4

(5.0)

(5.1)

(5.2)

(4.3)

(5.1)

(4.9)

(5.0)

(4.4)

2228

2182

2167

1933

1821

1758

1858

1743

(938)

(861)

(841)

(732)

(828)

(772)

(691)

(641)

18.3

11.7

7.19

5.5

6.8

5.2

4.9

4.7

(38.7)

(23.0)

(15.5)

(11.4)

(16.0)

(12.1)

(11.1)

(10.3)

Ethnicity %

BMIa, kg/m2 (SD)

Calories, kcal/d (SD)

Alcohol, g ethanol/d

989

989

(SD)

989

989

Smoking, %
Never

360

26.6

31.1

44.4

47.5

348

27.5

32.8

37.8

45.1

Past

491

51.8

56.3

46.1

44.0

603

62.7

62.9

60.3

53.5

Current

126

21.6

12.6

9.5

8.5

38

9.9

4.3

1.9

1.4
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(Table continues)
Baseline (prediagnosis)
Quartile median

Follow-up (postdiagnosis)

N

Q1

Q2

Q3

Q4

N

Q1

Q2

Q3

Q4

None

18

4.0

3.0

1.0

0.4

52

9.1

4.0

5.2

3.6

<150 min/d

831

85.6

83.3

84.5

84.2

818

84.8

81.8

79.7

82.1

>150 min/d

129

10.4

13.7

14.5

15.5

119

6.2

14.2

15.1

14.3

>High school

128

16.5

14.7

12.7

7.7

128

18.0

12.9

11.4

9.4

High school

289

34.4

27.9

26.1

27.4

289

35.2

26.2

30.8

23.1

Some college,

446

40.4

46.3

47.5

49.8

446

40.8

48.0

44.8

50.7

126

8.8

11.0

13.7

15.1

126

6.0

12.9

13.0

16.8

108

11.2

12.1

8.4

11.2

220

23.2

22.3

20.6

23.8

66

7.0

5.1

7.7

7.0

553

53.9

59.0

52.7

54.5

291

27.8

32.4

33.1

27.3

457

35.

39.6

47.9

40.7

Physical activityb, %

Education, %

college
Post-graduate
Family historyc, yes
%
History of polyps,
yes %
NSAIDs used, current
%
Note.(N = 989). Kcal, kilocalories; SD, standard deviation; NSAIDs, non-steroid anti-inflammatory drugs.
a

BMI was calculated from self-reported height and weight at follow-up.

b

Physical activity level was specified as moderate to vigorous.

c

Family history of CRC was defined as participants’ baseline response of the disease in mother, father, or siblings.

d

NSAIDs use was based on self-reported use at follow-up as never used, past, or current usage of at least twice a week

for longer than one month.
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Table 2
Cohort Participants’ Ages at Cohort Entry, CRC Diagnosis, Death, and CRC-Specific Mortality by
Quartiles of Postdiagnosis HEI score
Quartiles

Q1

Q2

Q3

Q4

Age at entry, year (SD)

61 (8.5)

63 (8.1)

63 (7.5)

62 (8.0)

Age at CRC diagnosis, year (SD)

68 (8.4)

70 (8.4)

69 (8.4)

69 (8.1)

Age at death, year (SD)

81 (8.5)

83 (7.0)

81 (7.5)

82 (7.0)

Years from cohort entry to diagnosis (SD)

6.1 (3.4)

6.2 (3.4)

6.0 (3.4)

6.2 (3.2)

Person-years, prediagnosis
Years from CRC diagnosis to death or 12/31/2014

6549
12.5 (4.8)

12.4 (4.6)

Person-years, postdiagnosis
CRC-specific mortality, %

12.6 (4.5)

12.8 (4.4)

13,610
17.8

Note. (N = 989). CRC, colorectal cancer. HEI, Healthy Eating Index.
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15.5
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Table 3
Cox Regression Results on CRC-Specific Mortality Risk by Postdiagnosis HEI-2010 Quartiles and
Change.
Quartile1

HR

95% CI

p

1st quartile, 20-62 (low)

1.00 (ref)

2nd quartile, 63-69 (low)

1.39

0.687

2.796

0.362

3rd quartile, 70-76 (high)

0.87

0.399

1.887

0.721

4th quartile, 77-97 (high)

0.80

0.363

1.752

0.572

Change in score a,b
Low/low

1.00 (ref)

Low/high

2.00

1.020

3.992

0.044

High/low

0.59

0.260

1.346

0.211

Note. CRC, colorectal cancer. HEI, Healthy Eating Index.
a

Adjusted for sex, race, age at diagnosis, education level, postdiagnosis body mass index,

postdiagnosis daily energy intake, postdiagnosis alcohol consumption, physical activity, smoking
status, family history of CRC, history of intestinal polyps, and NSAIDs use.
b

HEI change high/high pairing not entered into regression model due to linear dependencies with the

low/high and high/low pairings.
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Abstract
Background: Colorectal cancer (CRC) is the third leading malignancy diagnosed in the
United States. While dietary fiber is inversely associated with incident-CRC and
mortality risk, there is little evidence if the same benefit applies to CRC-specific
mortality risk during survivorship. Objective: This study examined the impact of dietary
fiber intake postdiagnosis and the change from prediagnosis level on CRC-specific
mortality in survivors from the Multiethnic Cohort Study. (MEC) Methods: Adults ages
45 to 70 were recruited from Los Angeles County and the State of Hawaii between 1993
and 1996. Invasive CRC cases were identified between baseline and December 31, 2014.
A survey was administered to collect data on self-reported demographic and medical
history. Lifestyle data was collected through a culturally validated Food Frequency
Questionnaire. Cox proportional hazard regression was used to estimate CRC-mortality
risk based on postdiagnosis dietary fiber intake and change from baseline. Results: One
thousand one hundred and forty-one CRC survivors were included in this analysis. The
average age of incident-CRC diagnosis was 68.9 years old (SD = 8.3). There were 4.9
years (SD = 3.3) between diagnosis and follow-up surveys. The median dietary fiber
intake was 11.6 grams/day (g/d) per 1,000 kilocalories (kcal) with quartile medians of
7.9, 10.2, 11.8, and 14.5 g/d per 1000 kcal. Postdiagnosis intake in the 3rd and 4th
quartiles (25 g/d and 30 g/d, respectively) were associated with 58% and 52% lower
CRC-specific mortality risk compared to the 1st quartile (less than 20 g/d). Conclusion:
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Dietary fiber intake of at least 25 g/d was associated with the reduction in CRC-specific
mortality risk among a racially diverse group of survivors from the MEC.
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Introduction
Colorectal cancer (CRC) is the third leading malignancy, and the second most
common cause of cancer deaths in the United States (Siegel et al., 2020). In 2020,
104,610 new cases of colon cancer and 43,340 new cases of rectal cancer are expected
(Siegel et al., 2020). Despite the staggering incidence rate, the 5-year survival rates of
colon and rectal cancers are 64% and 67%, respectively, reducing approximately 1% per
year (American Cancer Society [ACS], 2019). With improved screening efforts and
treatment, CRC survivors are a growing population of over one million American men
and women. However, compared to primary prevention, less is understood about
secondary prevention in CRC. Moreover, most studies to date investigated non-Hispanic
White cohort participants. Considering that African Americans and Japanese Americans
report increased incidence risk (ACS, 2010; Jin, Pinheiro, Xu, & Amei, 2016), research
in racially diverse populations is urgently needed.
The relationship between dietary fiber and CRC initiation, recurrence, and
mortality risks is an intricate one. Fiber has long been known to increase stool mass and
colonic motility, thus shortening stool transit time, promoting regular bowel movements,
and reducing potential carcinogenic exposures to colonocytes (Perry & Ying, 2016).
Additionally, higher fiber intake results in higher short-chain acids production through
bacterial fermentation, yielding vital metabolites that strengthen the immune functions of
the gastrointestinal (GI) tract. In recent years, the microbiome has been linked to the risk
of multiple chronic diseases’ development, including cardiovascular disease, diabetes, GI
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disorders, and cancer (Perry & Ying, 2016). The microbiome composition varies vastly
between individuals by genetics, host physiology, age, and diet (Hollister, Gao, &
Versalovic, 2014).
Diet has a significant influence on the diversity and balance of the microorganism
communities. Interventional studies that manipulated fiber and fat contents of the diet
reported immediate changes in gut microbiome and metabolites linked to CRC risk
(O’Keefe et al., 2015; David et al., 2014). O’Keefe et al. (2015) demonstrated changes in
the luminal environment when African Americans were placed on a high-fiber, low-fat
diet, and native rural Africans consumed a high-fat, low-fiber diet for two weeks,
compared to their baseline intake, respectively (O’Keefe et al., 2014). The high-fiber,
low-fat diet increased butyrogenesis, reduced inflammatory markers, and decreased
colonocytes proliferation (O’Keefe et al., 2014). In healthy subjects, plant-based and
animal-based diets resulted in measurable changes in microbial diversity and gene
expression after five days (David et al., 2014), suggesting the anticarcinogenic role of
higher fiber intake. Meanwhile, CRC patients’ microbiome was perturbed compared to
cancer-free subjects (Saus, Iraola-Guzman, Willis, Brunet-Vega, & Gabaldon, 2019).
Additional studies also reported reduced relative risk when comparing high and low fiber
intakes. From the European Prospective Investigation into Cancer and Nutrition (EPIC)
study, Bingham et al. (2003) reported 42% relative risk reduction in CRC incidence,
approximately 8% reduction per increased quintile intake of three to five grams/day (g/d).
Later, Murphy et al. (2012) reported from an 11-year follow-up of the same cohort and
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found a dose-response-like effect by fiber intake— a 13% risk reduction per 10 g/d. A
meta-analysis of 25 prospective studies by Aune et al. (2011) reported that every 10 g/d
intake was correlated to an approximately 10% decrease in CRC incidence. However,
there were also reporting that fiber intake was inconsequential in CRC development (Lin
et al., 2005; Park et al., 2005; Schatzkin et al., 2007).
As the population of CRC survivors increase and age, the role of fiber in
secondary prevention demands further examination. Song et al. (2018) analyzed data
between 1980 to 2010 from the Nurses’ Health Study and the Health Professionals
Follow Up Study to address this question. Self-administered FFQ from the 1,575 cohort
participants with stages I, II, and III CRC provided pre- and postdiagnosis fiber intake.
For every five grams of cumulative fiber intake per day at baseline, there was a 22%
decrease in the risk of CRC-specific mortality risk. In survivors, per five g/d increase
compared to baseline intake was associated with a 12% decrease in CRC-specific
mortality (Song et al., 2018). In the Prostate, Lung, Colorectal, and Ovarian Cancer
Screening trial, of the 1,667 cases of incident adenomas, 738 participants developed
recurrent adenomas (Kunzmann et al., 2015). Higher grains and cereal fiber intakes were
linked to reduced recurrence of rectal adenomas; however, no other fiber sources or
bowel areas were associated with intakes (Kunzmann et al., 2015). Given the potentially
significant benefits in recurrent risk reduction, it was worthwhile to investigate if changes
in postdiagnosis fiber intake may improve CRC-free survival across racial groups.
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The present study addressed the gap in the literature by examining whether
postdiagnosis fiber intake, as well as changes from prediagnosis intake, are associated
with CRC-specific mortality risk in survivors in the Multiethnic Cohort Study (MEC). It
is hypothesized that an increase in fiber intake postdiagnosis is associated with a
reduction in CRC-specific mortality risk.
Methods
Study Population
The MEC is a prospective cohort study established to investigate the association
of lifestyle and genetic factors and with the development of cancer and chronic diseases
(Kolonel et al., 2000). The study’s design and data collection method have been
previously described (Kolonel et al., 2000). Sampling frames were developed using
publicly available information from driver’s license files, voter registration records, and
Medicare enrollment to achieve a racially and socioeconomically diverse participant
pool. Over 215,000 adults between the ages of 45- and 75-years old living in the state of
Hawaii and Los Angeles County consented to enroll from 1993 to 1996. MEC
participation was initiated when eligible individuals completed a self-administered
questionnaire that included baseline demographic information, medical history, and
detailed dietary assessment. Study participants were primarily of the following
race/ethnicities: African American, Native Hawaiian, Japanese American, Latino, and
non-Hispanic White. The institutional review boards of the University of Hawaii and the
University of Southern California approved the study protocol. Additionally, the Walden
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University institutional review board approved the present analysis (approval #01-08-200641131).
Dietary Assessment
The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000; Stram et al., 2000). Upon entry to
the cohort, participants completed a 26-page baseline questionnaire. As part of the
survey, a culturally tailored quantitative Food Frequency Questionnaire (FFQ) with more
than 180 items was included (Stram et al., 2000). The questionnaire assessed habitual
intake over the previous 12 months. Detailed instructions in English and Spanish were
provided along with images of portion sizes referenced in the multiple-choice responses.
The FFQ was validated and calibrated in ethnic-sex matched groups through repeated 24hour diet recalls on three separate occasions (Stram et al., 2000). The correlation for
dietary fiber densities (grams of intake per 1,000 kilocalories per day) ranged from .68 to
.79. Upon data collection, average daily nutrient intakes, including dietary fiber were
calculated using the food composition tables developed and maintained at the University
of Hawaii Cancer Center specifically for the use in the MEC (Murphy, 2002). Pre- and
postdiagnosis intakes of dietary fiber intake were assessed by baseline FFQ and the FFQ
following CRC diagnosis.
Case Ascertainment
The primary exclusion criterion was the presence or a history of CRC at baseline,
as identified from responses in the baseline questionnaire or the Surveillance,
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Epidemiology, and End Results Program (SEER) tumor registries in California and
Hawaii. The confirmation of CRC cases and tumor sites were based on the International
Classification of Disease for Oncology, third edition (ICD-O-3) codes (World Health
Organization [WHO], 2013). Sites included were cecum, appendix, ascending colon,
hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, large
intestine not otherwise specified, rectosigmoid junction, and rectum (C180-C189, C199,
C209, and C260). This information was then classified as colon, rectal, or mixed cancer.
CRC-specific deaths were verified through the State’s vital records of California and
Hawaii and the National Death Index. Participants who identified outside of the major
race/ethnicity groups of non-Hispanic white, African American, Japanese American,
Latino, and Native Hawaiian were excluded. Finally, participants who reported
implausible dietary intakes were also excluded (average daily energy exceeding 5,000
kcal and dietary fiber exceeding 100 g/d).
Statistical Analysis
Between baseline and follow up, there were 6,451 cases of invasive CRC
identified in the cohort. Among them, dietary data pre- and postdiagnosis were available
for 1,166 cases. After excluding dietary outliers, 1,141 participants remained in the
analysis. Missing data in the covariates were replaced with median value. A post-hoc
power analysis used a two-tailed alpha of .05, .25 effect size, and a 55% 10-year survival
rate, which yielded a statistical power of .88. For prediagnosis fiber intake, person-time
was calculated from the date of cohort entry to the date of incident-CRC diagnosis. For
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postdiagnosis fiber intake, the date of CRC diagnosis to the first instance of death,
censoring, or end of study was used to calculate the person-time.
Dietary fiber intake was standardized by density per 1,000 kilocalories (kcal).
Cox proportional hazard regression modeling was used to estimate CRC-specific
mortality risks as hazard ratios (HR) with 95% confidence interval (CI) for postdiagnosis
fiber intake and the change between pre- and postdiagnosis. Postdiagnosis intake was
calculated into quartiles and entered into the model for comparisons. For the change in
intake, daily averages were calculated by subtracting the prediagnosis intake from that of
postdiagnosis. The change in intake was grouped as followed: ≥ 5 g/d decrease, ≤ 5 g/d
decrease, ≤ 5 g/d increase, and ≥ 5 g/d increase. Using the least increased group as the
referent, the model computed the CRC-specific mortality risk for each level of change in
intake.
Univariate Cox regression models were used to evaluate model fit and HRs before
adjusting for covariates. Potential confounders were included in the subsequent models as
covariates: Age at diagnosis, sex, race, education, BMI, physical activities, smoking
status, history of intestinal polyps, family history of CRC, alcohol consumption, and total
energy. BMI was calculated from self-reported height and weight. Physical activity was
categorized as 0, up to 150, and more than 150 minutes per day of moderate to vigorous
exercise. Cigarette smoking status was never smoked, past smoker, and current smoker.
Education level was grouped as less than high school, high school, some college and
college, and graduate education. History of intestinal polyps was defined by participants’
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responses if their health care providers have ever informed them. Family history of CRC
was defined as participants’ affirmation of the disease in at least one biological parent or
sibling. Finally, NSAIDs use was based on self-reported use as never used, past use, or
current user. Wald statistics and likelihood ratio tests were used to check for interactions
and collinearity. Confidence interval (CI) and p-values < 0.05 were used to indicate
statistically significant results.
Sensitivity analysis was performed to exclude analysis of participants who
returned the postdiagnosis FFQ within 12 months of CRC diagnosis to account for the
potential influence on the diet from treatment. All analyses were performed in SPSS
version 25.
Results
The sample was composed of 622 men and 519 women. The racial distribution is
as following: 42.4% Japanese Americans, 26.6% non-Hispanic whites, 14.5% Latinos,
14.4% African Americans, and 7.1% Native Hawaiians. The mean follow-up was 18.7
years. Person-time was 6,975 years prediagnosis and 14,359 postdiagnosis. Table 1
4shows the baseline and follow-up characteristics of the participants by quartiles of
dietary fiber. At baseline, the median intake was 10.9 g/d per 1000 kcal (interquartile
range 8.3 to 14.1 g). Postdiagnosis, median intake was 11.6 g (interquartile range 9.3 to
14.3 g). Participants with higher fiber intake postdiagnosis tended to be females, were
more physically active, and consumed less alcohol.
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Table 5 presents the participants’ ages at critical events during the study period.
Participants averaged 62.3 years old (SD = 8.1) at cohort entry while the average age at
incident-CRC diagnosis was 68.9 years old (SD = 8.3). There were 4.9 years (SD = 3.3)
between diagnosis and the completion of follow-up FFQ. In this group of survivors,
there were approximately three times more colon cancers (73.8%) than rectal cancers
(25.4%). Between the two cancer types, a higher proportion of colon cancer survivors
reported fiber intake in the upper quartiles (Table 6).
The hazard ratios of postdiagnosis fiber intake and the change in intake on CRCspecific mortality are shown in Table 7. In the univariate models, the postdiagnosis intake
and change in intake did not show an association with CRC-specific mortality (results not
shown). After adjusting for covariates, postdiagnosis intakes in the 3rd and 4th quartiles
were associated with 58% and 52% reduction in CRC-specific mortality risk, respectively
(HR = 0.42; 95% CI [0.2, 0.82]; p = .011 and HR = 0.48; 95% CI [0.24, 0.97]; p = .041,
respectively). Based on the average caloric intake, the quartile medians equate to
approximately 26.0 g and 29.9 g of dietary fiber daily postdiagnosis. On the contrary, the
change in intake did not reach statistical significance in CRC-mortality risk. Sensitivity
analysis excluding participants who completed their postdiagnosis survey within the first
year was consistent where intake in the 3rd and 4th quartiles were inversely associated
with lowered CRC-specific mortality.
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Discussion
In the general population, dietary fiber is an integral part of a healthy diet. The
results here suggest that intake over approximately 25 g daily was associated with over
50% lower CRC-specific mortality risk in this sample. However, the change in intake
level was found to be irrelevant. In other words, regardless of prediagnosis intake level,
achieving at least 25 g/d, which coincides with the minimal adequacy in the Dietary
Guidelines for Americans (U.S. Department of Health and Human Services and U.S.
Department of Agriculture, 2015), may promote CRC-free living in long term
survivorship.
The findings align with some of the existing literature. In a previous study, Song
et al. (2018) reported a similar finding from the Nurses’ Health Study and the Health
Professionals Follow Up Study cohorts. They reported a 52% reduction in CRC-specific
mortality associated with intakes in the 3rd quartile and a 46% reduction associated with
the 4th quartile. However, the mortality risk observed from the change in intake did not
occur in this group of CRC survivors. One potential explanation is the timing of the
follow-up survey. Song et al. examined dietary data collected between six months and
four years postdiagnosis, whereas the average length of time in this sample was 4.9 years
(SD = 3.3) postdiagnosis. This may indicate that increased fiber intake during early
survivorship could provide additional health benefits during CRC treatment recovery and
intestinal adaptation.
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Limitations and Strengths
There are several limitations and strengths in this study. Since surgery is the
primary treatment for non-metastasized CRC, the lack of treatment methods— especially
the type of surgical resection performed, could have implications on dietary tolerance that
affected fiber intake. Second, the MEC cohort is based in Southern California and
Hawaii, which may limit the findings’ generalizability to CRC patients in other regions.
On the other hand, the total follow-up period was 18.7 years, with an average of 12.6
years (SD = 4.6) postdiagnosis. This length of follow-up allows for a comprehensive
period to capture mortality occurrence. Additionally, this study provided much-needed
data about racial minorities, who have a disproportionately higher of incidence of CRC
diagnoses in the US (Siegel et al., 2020).
Conclusion
High fiber intake has been linked to lower incident-CRC risk. The present
analysis suggested significant benefits in CRC-specific mortality risk during long term
survivorship in a racially and socioeconomically diverse sample. Future studies may
expand on geography for recruitment, such as the Appalachia, southern, and midwestern
regions in the US due to some of the highest incident-CRC rates. Meanwhile, the types
and sources of fiber are also of interest as the evidence may be incorporated into dietary
education. A potential new area to investigate may be the recurrent and mortality risk
with the timing of increasing dietary fiber intake postdiagnosis.

74

75
References
American Cancer Society. (2019). Key statistics for colorectal cancer. Accessed 2019,
August 16 from https://www.cancer.org/cancer/colon-rectal-cancer/about/keystatistics.html
Aune, D., Chan, D. S. M., Lau, R., Vieira, R., Greenwood, D., Kampman, E., & Norat, T.
(2011). Dietary fibre, whole grains, and risk of colorectal cancer: Systematic
review and dose-response meta-analysis of prospective studies. British Medical
Journal, 343, d6617. Doi:10.1136/BMJ.d6617
Bingham, S. A., Day, N. E., Luben, R, Ferrari, P., Slimani, N., Norat, T., . . . Riboli, E.
(2003). Dietary fibre in food and protection against colorectal cancer in the
European Prospective Investigation into Cancer and Nutrition (EPIC): An
observational study. Lancet, 362, 1496-1501. Doi:10.1016/s0140-6736(03)131741
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B.
E., . . . Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human
gut microbiome. Nature, 505, 559-563. Doi:10.1038/nature12820
Hollister, E. B., Gao, C., & Versalovic, J. (2014). Compositional and functional features
of the gastrointestinal microbiome and their effects on human health.
Gastroenterology, 146, 1449-1458.

75

76
Jin, H., Pinheiro, P. S., Xu, J., & Amei, A. (2016). Cancer incidence among Asian
American populations in the United States, 2009-2011. International Journal of
Cancer, 138, 2136-2145.
Kolonel, L. N., Henderson, B. E., Hankin, J. H., Nomura, A. M. Y., Wilkens, L. R., Pike,
M. C., . . . Nagamine, F. S. (2000). A multiethnic cohort in Hawaii and Los
Angeles: baseline characteristics. American Journal of Epidemiology, 151, 34657.
Kunzmann, A. T., Coleman, H. G., Huang, W-Y., Kitahara, C. M., Cantwell, M. M., &
Bernstein, S. I. (2015). Dietary fiber intake and risk of colorectal cancer and
incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian
Cancer Screening Trial. American Journal of Clinical Nutrition, 102, 881-890.
Doi:10.3945/ajcn.115.113282
Lin, J., Zhang, S. M., Cook, N. R., Rexrode, K. M., Liu, S., Manson, J. E., . . . Buring, J.
E. (2005). Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal
cancer in a prospective cohort of women (United States). Cancer Causes and
Control, 16, 225-233. Doi:10.1007/s10552-004-4025-1
Murphy, N., Norat, T., Ferrari, P., Jenab, M., Bueno-de-Mesquita, B., Skeie, G., . . .
Riboli, E. (2012). Dietary fibre intake and risks of cancers of the colon and
rectum in the European Prospective Investigation into Cancer and Nutrition
(EPIC). PLoS One, 7(6), e39361.

76

77
Murphy, S. P. (2002). Unique nutrition support for research at the Cancer Research
Center of Hawaii. Hawaii Medical Journal, 61, 15-17.
O’Keefe, S. J. D., LatinLi, J. V., h, L., Ou, J., Carbonero, F., Mohammed, K., . . .
Zoetendal, E. G. (2015). Fat, fibre and cancer risk in African Americans and rural
Africans. Nature Communications, 6, 6342-6355. Doi:10.1038/ncomms7342
Park, Y., Hunter, D. J., Spiegelman, D., Bergkvist, L., Berrino, F., van den Brandt, P. A.,
. . . Smith-Warner, S. A. (2005). Dietary fiber intake and risk of colorectal cancer,
a pooled analysis of prospective cohort studies. Journal of the American Medical
Association, 294(22), 2849-2857.
Perry, J. R. & Ying, W. (2016). A review of physiological effects of soluble and
insoluble dietary fibers. Journal of Nutrition and Food Science, 6(2), 1000476.
Doi:10.4172/2155-9600.1000476
Saus, E., Iraola-Guzman, S., Willis, J. R., Brunet-Vega, A., & Gabaldon, T. (2019).
Microbiome and colorectal Cancerc: Roles in Carcinogenesisc and clinical
potential. Molecular Aspects of Medicine, 2997(19), 30032-30039.
Doi:10.1016/j.mam.2019.05.001.
Siegel, R. L., Miller, K. D., Sauer, A. G., Fedewa, S. A., Butterly, L. F., Anderson, J. C., .
. . Jemal, A. (2020). Colorectal cancer statistics, 2020. CA: A Cancer Journal for
Clinicians, 70(3), 145-164. Doi:10.3322/caac.21601
Schatzkin, A., Mouw, T., Park, Y., Subar, A. F., Kipnis, V., Hollenbeck, A., . . .
Thompson, F. E. (2007). Dietary fiber and whole-grain consumption in relation to
77

78
colorectal cancer in the NIH-AARP diet and health study. American Journal of
Clinical Nutrition, 85, 1353-1360.
Song, M., Kana, W., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., . . . Chan, A.
T. (2018). Fiber intake and survival after colorectal cancer diagnosis. Journal of
the American Medical Association Oncology, 4(1), 71-79.
Doi:10.1001/jamaoncol.2017.3684
Stram, D. O., Hankin, J. H., Wilkens, L. R., Pike, M. C., Monroe, K. R., Park, S., . . .
Kolonei, L. N. (2000). Calibration of the dietary questionnaire for a multiethnic
cohort in Hawaii and Los Angeles. American Journal of Epidemiology, 151, 358370.
U.S. Department of Health and Human Services and U.S. Department of Agriculture.
(2015) 2020 Dietary Guidelines for Americans. 8th Edition. Accessed 2020, June
25 from https://health.gov/our-work/food-and-nutrition/2015-2020-dietaryguidelines
World Health Organization. (2013). International classification of diseases for oncology
(ICD-O), 3rd edition. Accessed 2020, June 25 from
https://apps.who.int/iris/handle/10665/96612

78

79
Tables and Figures
Table 4
Baseline and Follow-up Characteristics of the Incident-CRC Survivors in the MEC by Quartiles of Fiber Iintake.
Baseline (prediagnosis)
Quartile median

Follow-up (postdiagnosis)

n

Q1

Q2

Q3

Q4

n

Q1

Q2

Q3

Q4

1141

6.9

9.6

12.2

16.9

1141

7.9

10.2

11.8

14.5

1141

4.3

6.2

7.9

9.7

1141

4.7

6.2

7.8

9.0

1141

5.9

8.5

10.2

13.4

1141

6.8

8.6

10.3

11.8

Men %

622

75.4

58.1

51.0

33.8

622

74.3

62.8

52.6

36.3

Women %

519

24.6

41.9

49.0

66.2

519

25.7

37.2

47.4

63.7

White

246

18.2

20.4

21.9

25.6

246

21.8

19.6

22.2

22.3

African American

164

9.8

15.1

15.8

16.7

164

12.9

14.0

14.9

15.1

Native Hawaiian

81

12.6

8.7

3.5

3.9

81

13.4

6.8

6.3

4.1

Japanese American

484

51.9

44.5

42.9

30.2

484

43.6

44.8

44.8

36.3

Latino

166

7.4

11.3

15.8

23.5

166

8.4

14.8

11.8

22.3

1141

26.8

27.0

26.6

26.2

1141

26.7

26.6

26.8

26.5

(4.8)

(5.4)

(4.9)

(4.8)

(4.7)

(5.0)

(4.9)

(5.3)

2327

2178

2075

1926

2168

2069

2201

2062

(906)

(857)

(825)

(771)

(875)

(875)

(885)

(768)

23.8

9.4

5.6

3.8

16.5

11.7

9.0

5.7

(40.0)

(21.3)

(11.0)

(8.5)

(30.6)

(28.6)

(20.4)

(17.4)

Total fiber Intake,
g/1000 kcal/d
Soluble fiber intake,
g/d
Insoluble fiber
intake, g/d

Ethnicity %

BMIa, kg/m2 (SD)

Calories, kcal/d (SD)

Alcohol, g ethanol/d
(SD)

1141

1141

1141

1141

(Table continues)
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Baseline (prediagnosis)

Follow-up (postdiagnosis)

n

Q1

Q2

Q3

Q4

n

Q1

Q2

Q3

Q4

Never

424

24.8

33.2

43.3

48.2

410

24.3

31.2

40.1

42.5

Past

558

53.2

53.8

47.2

43.9

682

63.4

62.8

58.2

56.8

Current

147

22.0

13.0

9.4

7.9

49

12.4

6.0

1.8

0.7

No exercise

23

2.5

1.5

2.9

1.1

61

8.4

6.4

4.8

3.1

< 150 min/d

953

84.3

85.9

82.1

85.6

913

81.7

80.8

84.4

81.8

> 150 min/d

153

13.2

12.6

14.9

13.3

139

9.9

12.8

10.8

15.1

>High school

147

9.1

12.8

16.8

12.5

147

10.4

13.2

12.6

14.7

High school

330

34.7

26.8

25.8

28.5

330

32.2

31.2

28.0

26.0

4-year college

525

45.3

48.3

45.5

45.2

525

49.0

43.2

46.3

45.9

Post-graduate

139

10.9

12.1

11.9

13.9

139

8.4

12.4

13.1

13.4

122

12.3

10.9

11.0

8.5

256

26.2

23.2

21.2

20.9

77

5.3

7.2

7.7

6.8

626

66.3

52.4

51.4

53.8

332

26.0

30.6

32.3

31.7

509

43.1

48.0

43.8

43.8

Smoking %

Physical activityb %

Education %

Family historyc, yes %
History of polyps, yes
%
NSAIDs used, current
%

Note. CRC, colorectal cancer; MEC, multiethnic cohort study; kcal, kilocalories; SD, standard deviation; NSAIDs,
non-steroid anti-inflammatory drugs.
a

BMI was calculated from self-reported height and weight at follow-up.

b

Physical activity level was specified as moderate to vigorous.

c

Family history of CRC was defined as participants’ baseline response of the disease in mother, father, or siblings.
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d

NSAIDs use was based on self-reported use at follow-up as never used, past, or current usage of at least twice a week

for longer than one month.
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Table 5
The Age of Cohort Entry, Diagnosis, and Death in CRC Survivors by Quartiles of Dietary Fiber
Intake Postdiagnosis
Q1

Q2

Q3

Q4

Age at entry, y (SD)

60.7 (8.7)

62.7 (8.3)

62.9 (7.7)

63.2 (7.2)

Age at diagnosis, y (SD)

67.0 (8.8)

69.6 (8.5)

69.4 (8.1)

69.8 (7.5)

Age at death, y (SD)

80.9 (8.7)

81.9 (7.3)

82.1 (7.0)

81.7 (7.2)

Years from cohort entry to CRC diagnosis

5.9 (3.2)

6.4 (3.4)

6.1 (3.3)

6.1 (3.4)

12.7 (4.7)

12.2 (4.7)

12.5 (4.4)

12.8 (4.5)

(SD)
Years from CRC diagnosis to death or
12/31/2014 (SD)
Note. CRC, colorectal cancer; SD, standard deviation.

82

83
Table 6
Incident-CRC Tumor Site and CRC-Specific Mortality by Quartiles of Dietary Fiber Intake
Postdiagnosis
N

Q1

Q2

Q3

Q4

Colon

791

70.6

69.7

77.1

76.0

Rectum

279

28.3

29.9

22.1

23.2

Mixed

8

1.1

0.4

0.7

0.7

49

25.9

25.5

11.2

18.5

Tumor site %

CRC-specific mortality (%)
Note. CRC, colorectal cancer.
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Table 7
CRC-Specific Mortality Risk by Fiber Intake and Its Change Postdiagnosis in the Multiethnic
Cohort
HR

95% CI

p-value

Postdiagnosis fiber intake,

2.9-9.3 (1st)

Ref

g/d per 1000 kcal (quartile)

9.3-11.6 (2nd)

0.74

0.42-1.30

0.293

11.6-14.3 (3rd)

0.42

0.21-0.82

0.011

14.3-33.4 (4th)

0.48

0.24-0.97

0.041

Fiber change postdiagnosis,

> 5 g/d decrease

Ref

g/d per 1000 kcal

< 5 g/d decrease

1.36

0.56-3.31

0.502

< 5 g/d increase

1.78

0.73-4.24

0.210

> 5 g/d increase

2.91

0.98-8.66

0.055

Note.(N = 1,141) a,b. CRC, colorectal cancer.
a

HRs and 95% CIs were obtained by Cox regression.

b

Adjusted for sex, race, education level, BMI, physical activity level, caloric intake, alcohol

consumption, family history of CRC, history of polyps, age at diagnosis, smoking status, and
NSAIDs use.
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Abstract
Background: Dietary fat is a heterogeneous group of nutrients that are essential to healthy
living. Fatty acid subtypes have been shown to affect incident cancer risk based on their
pro- or anti-inflammatory properties. In colorectal cancer (CRC), fat from meat sources
and processed foods was associated with neoplastic initiation while fat from plants and
fish was associated with reduced incident and mortality risk. Objective: To examine the
role of total fat intake and fat from fish and shellfish postdiagnosis in CRC-specific
mortality risk among survivors in the Multiethnic Cohort Study. Method: Adults ages 45
to 75 from Los Angeles County, California, and the State of Hawaii were recruited
between 1993-1996. Baseline and subsequent surveys included a culturally validated
food frequency questionnaire to collect dietary data from self-reporting intakes. Followup surveys were conducted every 4 to 6 years. Results: One thousand one hundred and
forty-one participants were included in the final analysis. Total fat and fat from fish and
shellfish intake postdiagnosis were not associated with CRC-specific mortality risk (HR
= 1.48, 95% CI [.74, 2.95] and HR = 1.24, 95% CI [.58, 2.66], respectively).
Furthermore, no statistical significance was observed with changes in intakes
postdiagnosis (HR = .56, 95% CI [.28, 1.11] and HR = 1.29, 95% CI [.69, 2.39],
respectively). Sensitivity analysis restricting risk estimation from survivors who
responded at least 12 months after diagnosis showed consistent results. Conclusion: The
findings align with existing literature that total fat intake did not affect secondary CRC
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mortality risk whereas the fat from fish and shellfish intake was non-significant when
assessing the potential benefits form all fatty acids combined.
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Introduction
Colorectal cancer (CRC) is the third leading malignancy diagnosis and the second
cause of cancer deaths in the United States (American Cancer Society [ACS], 2019).
First-time colon and rectal cancer are expected to reach 104,610 and 43,340 cases in
2020, respectively (Siegel et al., 2020). In 2015, the 5-year survival rates of colon and
rectal cancers were 64% and 67%, respectively, declining at approximately 1% per year
since the previous decade (ACS, 2019). With improved screening efforts and treatment,
CRC survivors are a growing population of over one million American men and women.
However, the prevention of CRC recurrence, including using lifestyle strategies, is not
well understood. Moreover, most large-scale cohorts to date are composed of primarily
non-Hispanic White participants. Because CRC incidence risk has been rising among
African and Japanese Americans, research in racially diverse populations was needed
(ACS, 2019; Jin, Pinheiro, Xu, & Amei, 2009).
Diet has been demonstrated to correlate with incidence and mortality risks in
CRC. One of the mediators between dietary fat and CRC pathogenesis is via increased
primary bile acids secretion in response to intake. Although bile acids level alone is not
associated with the initiation of CRC, its level was found to correlate with biomarkers of
cell proliferation and mucosal inflammation in humans (Boleij & Tjalsma, 2012).
Additionally, the mechanism in which saturated fatty acids (SFAs) and trans fatty acids
may increase CRC incidence risk due to their proinflammatory properties (Doerner et al.,
2016; Viggiano et al., 2016), stem cell regulation disruption (Beyaz et al., 2016), altered
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prostanoid metabolism (Wang & DuBois, 2013), and modulation of the gut microbiota
(Yoshimoto et al., 2013). However, in a retrospective case-control study of over 4,000
Canadians, total fat intake was not associated with incidence CRC risk, and neither was
SFAs, monounsaturated fatty acids (MUFAs), or polyunsaturated fatty acids (PUFAs;
Sun et al., 2012). In a meta-analysis of 18 studies, no association was found between
CRC risk and total fat, SFAs, MUFAs, and PUFAs intake (Kim & Park, 2018). This
finding highlights that additional nutritional and socioenvironmental factors likely
modify dietary fat's effect on CRC development.
Among the subtypes of fatty acids, omega-3 (ω-3) PUFAs, particularly those from
marine sources, may be protective against CRC development (Norat et al., 2005; Kato,
Majumdar, Land, Barnholtz-Sloan, & Severson, 2010; Song et al., 2014). Norat et al.
(2005) reported from over 428,000 participants across 10 European countries in the
European Prospective Investigation into Cancer and Nutrition (EPIC) study that fish
consumption of > 80 grams/day (g/d) reduced CRC incidence risk by 31% when
compared to < 10 g/d.
On the contrary, neither marine ω-3 nor ω-6 intake was associated with CRC risk
reduction in an analysis combining data from the Nurses' Health Study and Health
Professional Follow-up Study by Song et al. (2014). Instead, marine ω-3 intake was
nonsignificantly associated with an increased risk of distal colon cancer but potentially
protective against rectal cancer. This finding was in line with physiological
characteristics that the presence of gut bacteria is most concentrated in the proximal
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colon, resulting in more robust cellular protection from fiber fermentation, creating a
gradient of weakening defense toward the distal colon (Yoshimoto et al., 2013). Second,
based on cellular data, rectal tissues are susceptible to inflammation, and oxidative stressinduced carcinogenesis (Yesudhas, Gosu, Anwar, & Choi, 2014), thus marine ω-3's antiinflammatory property may counter cellular damages associated with CRC development.
To date, few studies investigated, prospectively, the postdiagnostic and the
change from pre and postdiagnostic intake of fat from marine sources in CRC survivors.
In one of the most comprehensive studies with CRC survivors, 1,659 participants from
the Nurses’ Health Study and Health Professionals Follow Up Study were followed for a
median of 10.4 years. Survivors who increased marine ω-3 intake by > 0.15 g/d
experienced a 70% CRC-specific mortality risk reduction compared to unchanged intake
(Song et al., 2017). In another prospective study, 1,011 stage III CRC survivors were
followed for a median of seven years (Van Blarigan et al., 2018). The highest quartile of
ω-3 intake was associated with a 32% risk reduction in recurrence (Van Blarigan et al.,
2018).
The growing survivor population demands practical secondary prevention
guidelines and strategies. This study examined whether changes in total dietary fat intake
postdiagnosis, including fat from fish and shellfish, affect CRC-specific mortality risk in
survivors in the Multiethnic Cohort Study. (MEC)
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Materials and Methods
Study Population
The MEC is a prospective cohort study initiated to investigate the association of
lifestyle and genetic factors and with the development of cancer and chronic diseases
(Kolonel et al., 2000). The study’s design and data collection method have been
previously described (Kolonel et al., 2000). Over 215,000 adults living in Hawaii and Los
Angeles County between the ages 45 and 75 years old were enrolled from 1993 to 1996.
Publicly available information from driver’s license files, voter registration records, and
Medicare enrollment was used to develop sampling frames that are racially and ethnically
diverse. MEC participation was established when eligible individuals completed a selfadministered baseline questionnaire that included demographic information, medical
history, and a detailed dietary assessment. Study participants were primarily of the
following race/ethnicities: African American, Native Hawaiian, Japanese American,
Latino, and non-Hispanic White. The institutional review boards of the University of
Hawaii and the University of Southern California approved the study protocol.
Additionally, the Walden University institutional review board approved the present
analysis (#01-08-20-0641131).
Dietary Assessment
The MEC’s questionnaire development, sampling method, and data collection
have been previously published (Kolonel et al., 2000; Stram et al., 2002). Upon entry to
the cohort, participants completed a 26-page baseline questionnaire. As part of the
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survey, a culturally tailored quantitative Food Frequency Questionnaire (FFQ) with more
than 180 items was included (Stram et al., 2002). The FFQ was validated and calibrated
in ethnic-sex matched groups through 3 repeated 24-hour diet recalls. The questionnaire
assessed habitual intake over the previous 12 months. Detailed instructions in English
and Spanish were provided along with images of portion sizes referenced in the multiplechoice responses. Average daily nutrient intakes were calculated using the food
composition tables developed and maintained at the University of Hawaii Cancer Center,
specifically for the use in the MEC (Murphy, 2002).
Case Ascertainment
The MEC dataset is linked to the Surveillance, Epidemiology, and End Results
Program tumor (SEER) registries in California and Hawaii for the identification of CRC
cases. For CRC-specific death ascertainment, records from the States’ death certificate
records and the National Death Index were used for confirmation. The main exclusion
was a history or presence of CRC at baseline, as identified from responses in the baseline
questionnaire or the tumor registries. Furthermore, participants who identified outside of
the major race/ethnicity groups of African American, Native Hawaiian, Japanese
American, Latino, and white are excluded. Finally, participants with implausible
responses regarding dietary intakes are also excluded.
Statistical Analysis
Between baseline and follow up, 6,451 MEC participants were diagnosed with
invasive CRC, in which postdiagnosis dietary data were available from 1,166 of them.
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After excluding implausible dietary intakes of over 5,000 kcal average daily energy and
over 100 grams of daily dietary fiber intakes, 1,141 participants remained in the final
sample. Missing data were handled with median replacements. Post-hoc power analysis
for Cox proportional hazard regression used a two-tailed alpha of 0.05, 0.25 effect size,
and assuming a 55% 10-year survival rate, which yielded a statistical power of 0.8777.
For postdiagnosis intake as well as the change in intake, person-time was calculated from
the date of CRC diagnosis to the first instance of death, censoring, or end of the study
period on December 31, 2014.
Multivariate Cox proportional hazards regression models were used in calculating
the hazard ratios (HRs) and 95% confidence intervals (CIs) for CRC-specific deaths.
Intakes of total fat were standardized into percent of energy for analysis. For the changes
in intakes, prediagnosis intake reported at baseline was subtracted from the postdiagnosis
intakes at follow-up. All intake and change levels were calculated into quartiles and used
to estimate HRs for mortality risk. Demographic characteristics, clinicopathological,
lifestyle, and dietary predictors for CRC outcomes were included as covariates in the
models (age at diagnosis, sex, race, education level, physical activities, smoking status,
history of intestinal polyps, family history of CRC, BMI, total energy, and alcohol
consumption). Education levels were classified as less than high school, some college,
and college graduate. A history of intestinal polyps was defined by participants'
affirmative response to the detection of the condition. A family history of CRC was
determined by participants' baseline reports of CRC in first-degree family members. BMI
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was calculated from self-reported height and weight postdiagnosis and entered as a
continuous covariate. Physical activity was grouped into less than or more than 150
minutes of daily activities at moderate to vigorous intensity. Self-reported cigarette
smoking status was never smoked, past smoker, or current smoker. Finally, energy and
alcohol consumption were calculated from FFQ responses. Wald statistics and likelihood
ratio tests were used to check for interactions and collinearity.
Sensitivity analysis was performed by excluding participants who returned the
postdiagnosis FFQ within 12 months of CRC diagnosis to limit the potential influence on
the diet from treatment. All analyses were performed in SPSS version 25.0 (IBM
Corporation, Armonk, NY). All statistical tests were two-sided, p < 0.05 was considered
statistically significant.
Results
Among the 1,141 participants who were diagnosed with invasive CRC, 54.5% of
them were men. Table 8 details the participants' characteristics. This cohort of CRC
survivors included 42.4% Japanese Americans, 21.6% non-Hispanic Whites, 14.5%
Latinos, 14.4% African Americans, and 7.1% Native Hawaiians. Average BMI was 26.3
kg/m2 (SD = 4.9), energy intake was 1,798 kcal (SD = 735), and alcohol consumption
was 5.4 g ethanol per day (SD = 12.5). The majority of the participants reported regular
physical activities of moderate to vigorous levels (%). Most of them were either never or
past cigarette smokers both before and after incident-CRC diagnosis.
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The mean follow-up was 18.7 years. The average age of incident-CRC diagnosis
was 68.9 years old (SD = 8.3). There was an average of 4.9 years (SD = 3.3) between
incident-CRC diagnosis and the completion of the postdiagnosis FFQ (Table 9). The
CRC-specific mortality rates were 23.1% for the participants in the lowest intake quartile
of total fat and 28.3% for the highest intake quartile. For the intake of fat from fish and
shellfish, an inverse relationship emerged at 37.5% and 19.8% from the lowest and
highest intake quartiles, respectively.
Median total fat intake was 64 g/d pre- and 58 g/d postdiagnosis. Postdiagnosis,
median intakes of fatty acid subtypes were 17 g/d for saturated fat, 22 g/d for
monounsaturated fat, 13 g/d for polyunsaturated fat, and 1.5 g/d for omega-3 fatty
acids— all of which were lower than prediagnosis levels (data not shown). Intake of fat
from fish and shellfish decreased from 0.70 g/d prediagnosis to 0.65 g/d postdiagnosis.
Table 3 10presents the HRs and 95% CI for CRC-specific mortality risk estimated from
both the unadjusted and adjusted models. There was no statistically significant
association between either postdiagnosis total fat intake or fat from fish and shellfish and
CRC-specific mortality risk (HR = 1.48, 95% CI [.74, 2.95], p = .264 and HR = 1.24,
95% CI [.58, 2.66], p = .585, respectively). Furthermore, the two sources of fat's change
in intakes did not reach statistical significance in their association with CRC-specific
mortality risk. Compared to at least 5% increase in total fat intake, CRC survivors who
reported at least 5% decrease in fat as energy had an HR = .56 (95% CI [.28, 1.11], p =
.095). Similarly, those who increased intake of fat from fish and shellfish sources by at
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least 0.25 g/d did not experience significant differences in CRC-specific mortality
compared to those decreased consumption by at least 0.25 g/d (HR = 1.29, 95% CI [.69,
2.39], p = .423). Sensitivity analysis restricting risk estimation from survivors who
responded at least 12 months postdiagnosis did not change the results.
Among covariates in the models, older age at diagnosis was associated with
slightly increased risk with CRC-specific mortality (HR = 1.045, 95% CI [1.015, 1.077],
p = 0.003). Being a current smoker postdiagnosis significantly increased risk (HR = 3.61,
95% CI [1.658, 7.870], p = 0.001). Meanwhile, participants who reported having been
informed of the presence of intestinal polyps experienced a 48% reduced mortality risk
(95% CI [0.339, 0.801], p = 0.003).
Discussion
My results did not link the total fat intake level and that from fish and shellfish to
CRC-specific mortality risk among invasive CRC survivors. In addition, the change in
intake levels postdiagnosis, including a decrease in fat as a percent of total energy or an
increase in fish and shellfish sources, did not statistically significantly affect CRCspecific mortality risk in long-term survivorship.
The lack of association between total fat intake and CRC-specific mortality risk
aligns with a previous study in which fat intake during survivorship did not impact CRCrecurrence, or all-cause mortality risks in 1,011 stage III CRC survivors (Van Blarigan et
al., 2018). In that cohort, quartile median intakes were 57, 68, 76, and 87 g/d. In the MEC
cohort, participants reported lower quartile medians of 40, 60, 64, and 78 g/d. Our result
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supports that total fat intake during CRC survivorship had little to no impact on CRCspecific mortality risk, which appears to be consistent across a range of consumption
levels. This finding is not surprising given the heterogeneity of fatty acids and their proor anti-carcinogenic properties. The role of dietary fat in CRC survivorship may be
manifested partly via bodyweight as a result of an individual's metabolic state and energy
balance post-cancer.
Interestingly, the change in fat intake—neither increased nor decreased, had no
impact on CRC-specific mortality risk in our cohort. One potential explanation is that
cancer, as a disease state, and its related treatment is known to increase the patient's risk
of cancer cachexia that may last beyond the active cancer phase. Also, GI functions may
be altered following curative treatment and interfere with nutritional status.
Consequently, total fat intake likely affects each individual differently, elucidating a
consistent pattern on long-term health outcomes among CRC survivors.
On the contrary, the intake of fish and shellfish has been suggested to be
protective against incident-CRC (Aglago et al., 2020; Schwingshackl, et al., 2018)
However, such health benefits may be highly specific to one type of PUFA, marine ω-3
fatty acids. For example, Song et al. (2014) reported no significance between fish or total
PUFAs intake and incident-CRC risk. But when Japanese researchers examined the
relationship between marine ω-3 PUFAs and rectal cancer in a large-scale cohort, they
reported a U-shape association. The intake level in the highest quintile showed a slightly
elevated incident-rectal cancer risk. Whereas, intake levels in the middle quintiles were
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protective (Sasazuki et al., 2010). Later, Song et al., (2017) examined the effect of marine
ω-3 PUFAs on CRC-specific mortality risk and reported a trend in mortality risk
reduction among survivors who consumed at least 0.3 g/d compared to 0.1 g/d (HR = .59,
95% CI [.35, 1.01]). Meanwhile, an increase of at least 0.15 g/d from prediagnosis intake
was associated with a 70% CRC-specific mortality risk reduction compared to those who
did not change their intake. However, the same association and trend were not observed
in our analysis.
This contradicting finding suggests that first, seafood consumption was not a
surrogate to marine ω-3 PUFAs intake, likely due to the full array of fatty acids besides
ω-3 PUFAs and only deep-water fish such as salmon and tuna are rich in ω-3 PUFAs.
Second, the top 10 most consumed seafood in the United States were shrimp, salmon,
canned tuna, tilapia, Alaska pollock, pangasius, cod, catfish, crab, and clams (National
Marine Fisheries Service, 2020). As such, risk estimates based on fat from fish and
shellfish are likely less granular compared to estimating from marine ω-3 PUFAs.
Other factors that were significantly associated with CRC-specific mortality risk
were older age at diagnosis, cigarette smoking postdiagnosis, and having a history of
intestinal polyps was. In particular, smokers exhibited over three times the risk compared
to participants who reported never smoked. On the other hand, consistent with the
evidence that regular screening can identify pre- and early-stage cancerous polyps, a
positive history may be a surrogate to early detection thus timely treatment.
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Strengths and Limitations
The present study has several strengths, as well as limitations. To my knowledge,
this is the first study on this topic among a racially diverse cohort of CRC survivors.
Additionally, the calibration of a culturally validated FFQ used in the MEC demonstrated
a high degree of reliability specific to fat intake, with correlation coefficients ranging
from 0.46 to 0.77 among race-sex pairings (Stram et al., 2002). Furthermore, there were
12 years between incident-CRC diagnosis and the end of study or death. The robust
length of follow-up allowed for a meaningful observation period to capture deaths where
CRC was listed as the primary cause. On the other hand, the cohort's location in the
Western region may involve socioenvironmental factors that may limit the findings
generalizability. Finally, it is uncertain if the sources and types of fish and shellfish may
contain toxins that could potentially affect secondary CRC risk.
Conclusion
Dietary fat has been a controversial nutrient for its role in chronic diseases,
including CRC. However, there has yet been consistent evidence on the types and
thresholds of fat that may protect against cancer recurrences. Emerging data points to the
lack of association between total fat intake and mortality risk among CRC survivors,
whereas there may be a protective effect by ω-3 PUFAs. The present study found no
association between postdiagnosis intake or the change in consumption and CRC-specific
mortality risk from total fat and seafood intake, aligning with existing literature. One
practice implication may be that nutrition education post-CRC can benefit from precise
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and specific communications regarding fish and shellfish selection and differentiate ω-3
PUFAs as the only fatty acids that have shown promising results in long-term
survivorship. Future studies may consider estimating CRC recurrence and mortality risks
with multiple variables to understand better the role of various types of fatty acids and
their sources. Further subanalysis on cultural preferences on the types of fish and
shellfish consumed and cooking methods may also be of interest.
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Tables and Figures
Table 8
Participant Characteristics at Baseline and Follow-up by Lowest and Highest Quartiles of Total Fat Intake and Fat
From Fish and Shellfish Among CRC survivors in the MEC
Baseline

Follow-up
Fish and

Total fat

shellfish

Fish and
Total fat

shellfish

Quartile

Q1

Q4

Q1

Q4

Q1

Q4

Q1

Q4

Cases

278

276

281

276

286

284

275

268

Total Fat, % kcal/d

21.5

37.5

29.2

30.8

23.9

39.1

30.2

33.2

Fat from fish and shellfish, g/d

0.60

0.87

0.17

1.81

0.49

0.69

0.16

1.94

Total fat, g/d

50.9

72.7

51.9

87.7

40.1

77.7

42.9

85.2

Saturated fat, g/d

14.1

21.1

16.1

24.6

11.3

23.1

13.7

23.9

Monounsaturated fat, g/d

17.9

26.3

18.9

31.5

14.6

30.1

16.5

32.4

Polyunsaturated fat, g/d

11.9

17.1

11.5

22.1

9.6

16.8

9.8

20.4

Men %

48.6

58.0

49.5

64.5

50.0

59.9

43.6

63.1

Women %

51.4

42.0

50.5

35.5

50.0

40.1

56.4

36.9

White

18.7

23.6

27.0

17.8

16.4

22.5

25.5

16.0

African American

9.4

21.7

16.0

12.7

10.5

21.8

16.7

11.9

Native Hawaiian

5.4

8.0

2.8

14.1

4.2

7.0

5.1

13.1

Japanese American

55.0

29.7

23.1

51.1

54.5

35.2

21.8

53.4

Latino

11.5

17.1

30.9

4.3

14.3

13.4

30.9

5.6

25.8

27.3

27.2

26.9

25.6

27.2

27.1

26.3

(SD)

(5.2)

(5.1)

(5.5)

(4.8)

(4.9)

(4.8)

(5.6)

(5.0)

Calories

1967

2150

1770

2651

1655

1816

1484

2353

(SD)

(781)

(841)

(738)

(867)

(665)

(755)

(660)

(765)

Median intake

Ethnicity %

BMIa, kg/m2
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(Table continues)
Baseline

Follow-up
Fish and

Total fat
Alcohol, g ethanol/d

shellfish

Fish and
Total fat

shellfish

10.7

11.0

8.1

11.8

8.4

3.3

5.7

7.5

(26.7)

(26.6)

(19.2)

(23.3)

(17.9)

(6.6)

(14.7)

(14.5)

Less than high school

12.6

13.8

17.4

9.1

13.3

12.7

17.1

9.3

High school

30.2

32.2

25.6

34.1

25.5

29.9

28.4

29.9

Some college and college

43.2

44.2

46.6

44.2

49.3

46.1

44.4

47.4

Post-college

14.0

9.8

10.3

12.7

11.9

11.3

10.2

13.4

0.7

3.7

2.9

0.7

3.8

6.3

6.5

4.9

< 150 min/day

84.1

79.5

84.0

81.5

82.2

84.5

83.3

78.7

>150 min/day

15.2

16.8

13.1

17.8

14.0

9.2

10.2

16.4

Never

46.4

27.4

41.7

33.1

42.7

27.8

37.8

28.7

Past

43.8

51.8

46.7

52.0

53.5

63.7

58.5

66.4

Current

9.8

20.8

11.6

14.9

3.8

8.5

3.6

4.9

Family historyc, %

11.5

10.5

7.8

10.5

21.7

17.3

22.9

24.3

History of intestinal polyps, %

6.8

5.8

6.4

5.1

51.4

57.0

47.3

60.4

NSAIDs used, current %

26.2

37.5

33.6

32.0

43.0

45.1

46.5

42.5

(SD)
Education %

Physical activityb %
No moderate to vigorous
activity

Smoking %

Note.(N = 1,141). MEC, Multiethnic cohort; kcal, kilocalories; g/d, grams per day; BMI, body mass index; SD, standard
deviation; NSAIDs, non-steroid anti-inflammatory drugs.
a

BMI was calculated from self-reported height and weight at follow-up.

b

Physical activity level was specified as moderate to vigorous.

c

Family history of CRC was defined as participants’ baseline response of the disease in mother, father, and/or siblings.
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d

NSAIDs use was based on self-reported use at follow-up as never used, past, or current usage of at least twice a week

for longer than one month.

Table 9
Cohort Participants’ Ages at Cohort Entry, CRC Diagnosis, Death, and CRC-Specific Mortality by
Quartiles of Fat Intakes at Postdiagnosis
Total fat as % energy
Quartiles

Fat from fish and shellfish

Q1

Q4

Q1

Q4

Age at entry, years (SD)

62.7 (7.7)

62.0 (8.4)

63.0 (7.8)

61.8 (8.0)

Age at diagnosis, years (SD)

69.0 (8.3)

68.6 (8.5)

69.5 (8.1)

68.6 (8.2)

Age at death, years (SD)

81.6 (7.2)

82.2 (7.5)

81.9 (7.2)

81.2 (7.6)

Years from cohort entry to CRC diagnosis

5.8 (3.3)

6.1 (3.4)

6.0 (3.3)

6.3 (3.3)

13.3 (4.4)

12.5 (4.6)

12.5 (4.6)

12.3 (4.6)

23.1

28.3

37.5

19.8

Years from CRC diagnosis to death or
12/31/2014
CRC-specific mortality, %

Note. (N = 1,141). CRC, colorectal cancer; SD, standard deviation.
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Table 10
CRC-Specific Mortality Risk by Quartiles of Postdiagnosis Total Fat, Fat From Fish and Shellfish,
and Their Changes in the MEC

Total fat intake, % kcal/d

HR

95% CI

p

9.1-27.1 (1st)

Reference

36.0-52.9 (4th)

Model 1

1.40

.79-2.46

.249

Model 2

1.48

.74-2.95

.264

Change in total fat intake,

> 5% decrease

Reference

% kcal/d

> 5% increase

Model 1

.74

.42-1.33

.315

Model 2

.56

.28-1.11

.095

Fat from fish and shellfish, g/d

0.0-0.30 (1st)

Reference

1.30-9.73 (4th)

Model 1

1.30

.77-2.21

.332

Model 2

1.24

.58-2.66

.585

Change in fat from fish and

> 0.25 decrease

Reference

shellfish, g/d

> 0.25 increase

Model 1

1.32

.80-2.19

.278

Model 2

1.29

.69-2.39

.423

Note. (N = 1,141)a. CRC, colorectal cancer.
a

HRs and 95% CIs were obtained by Cox regression.

Model 1: Unadjusted.
Model 2: Adjusted for sex, race, education level, BMI, physical activity level, energy intake, alcohol
consumption, family history of CRC, history of intestinal polyps, age at diagnosis, smoking status,
and NSAIDs use.
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Part 3: Summary
Integration of the Studies
CRC diagnoses are life changing. For those who completed curative treatment,
cancer recurrence and death from the disease are common concerns during long-term
survivorship. The SEM, as applied in cancer prevention, considers dietary choices a
personal-level factor in which an individual has significant decision-making power.
Consequently, public health education could indirectly reduce CRC-specific mortality
risk by encouraging survivors to adopt favorable dietary choices. Unfortunately, evidence
regarding diet and CRC recurrence is inconsistent.
The present dissertation study examined the association between the HEI-2010
score, dietary fiber intake, and dietary fat intake and CRC-specific mortality risk among
survivors. The results suggested that adherence to the DGA, intended for the general
population, as well as dietary fat intake, had little to no effect on recurrence-related
mortality risk. However, moderate to high dietary fiber intake was associated with
reduced risk, regardless of the prediagnosis level. Together, the findings highlight a need
to identify dietary indicators that reflect the altered GI physiology and anatomy postCRC. This study provides several practice implications for consideration. First, it is
critical to select appropriate dietary indices when evaluating diet quality among CRC
survivors. For example, both the DASH diet and the Dietary Inflammatory Index have
been observed to offer meaningful risk prediction among cancer patients. This
observation may be, in part, due to their objectives in chronic disease management.
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Second, the promotion of dietary fiber intake of at least 25 grams and toward the
recommended intake level of 30 grams per day for older adults was beneficial. According
to the results from the 2010 National Health and Nutrition Examination Survey, the
average dietary fiber intake was 16 g/d in the United States, in which African Americans
consumed the lowest level at 13 g/d and Hispanics reported the highest level at 17 g/d
(Hoy & Goldman, 2014). As such, clinical and public health professionals are advised to
incorporate personal-level factors within the SEM, including physical ability and cultural
preferences when developing individual nutrition plans (U.S. Department of Health and
Human Services and USDA, 2015). Finally, when discussing fish and shellfish
consumption, it is critical to address the health benefits of fish as a food group and
specific sources for marine ω-3 fatty acids that were associated with reducing mortality
risk.
Together, the studies point to the dietary needs of CRC survivors being different
from that of noncancer individuals. There is a need for assessment tools and nutrition
recommendations tailored to CRC survivors inclusive of racial minorities' cultural
practices. As seen in the study using the HEI as an evaluation tool, increasing conformity
to the DGA may not produce mortality risk reduction benefits compared to the DASH
diet index or the ACS’s dietary index promoting anti-inflammatory food choices in
existing literature. Meanwhile, education on adequate fiber intake, fish and shellfish
selection, smoking cessation, and routine monitoring also play critical roles in CRC
recurrence and mortality risk.
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Social Change
This study's results contribute to existing literature that in which recurrencerelated mortality risk was not associated with postdiagnosis intake of dietary fat, rather,
reduced by moderate to high fiber intake. The evidence improves our understanding on
CRC secondary prevention and for the first time, it extends the knowledge to America's
racial minorities. The diversity of the sample cohort could propel CRC survivorship care
to transcend upstream through the SEM beyond the personal level. For example, health
promotion of high fiber foods may increase the demand of in ethnic enclaves, thus
encourages food companies and grocers to scale up supplies. Such an increase in
availability may potentially raise consumption over time, creating a positive cycle. From
a population health standpoint, healthcare professional organizations and health insurance
carriers are potential stakeholders at the organizational level with vested interests to
participate in reducing CRC recurrence by applying these data.
Lasting behavioral changes require both willingness and capability to apply health
knowledge. In this context, America's social infrastructure remains an essential social
determinant in CRC survivors' dietary choices. Through acknowledging a potential path
to empower dietary decision-making, progress may be made toward greater health
equality.
Conclusion
A healthy diet is integral to long-term CRC survivorship. However, much
research is needed to improve the understanding of the optimal timing and consumption
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level following treatment. The takeaway is that CRC affects each person differently and
individually tailored diets based on a balance of nutritional value and GI tolerate are
critical as part of the survivor care plan. Finally, regular monitoring is one of the most
effective tools in early detection in both incident and recurrent CRC prevention.
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Appendix: The Healthy Eating Index 2010
The Healthy Eating Index-2010 (HEI-2010)1 Components and Scoring Standards (NCI,
2020).
Maximum

Standard for maximum

Standard for minimum

points

score

score of zero

5

≥ 0.8 cup equiv. per 1,000

Component

Adequacy:
Total fruits2

No fruit

kcal
Whole fruits3

5

≥ 0.4 cup equiv. per 1,000

No whole fruit

kcal
Total vegetables4

5

≥ 1.1 cup equiv. per 1,000

No vegetables

kcal
Greens and beans4

Whole grains

5

10

≥ 0.2 cup equiv. per 1,000

No dark green vegetables

kcal

or beans and peas

≥ 1.5 oz equiv. per 1,000

No whole grains

kcal
Dairy5

10

≥ 1.3 cup equiv. per 1,000
kcal
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No dairy
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Maximum

Standard for maximum

Standard for minimum

points

score

score of zero

Component

Total protein foods6

5

≥ 2.5 oz equiv. per 1,000

No protein foods

kcal
Seafood and plant

5

proteins6,7
Fatty acids8

10

≥ 0.8 oz equiv. per 1,000

No seafood or plant

kcal

proteins

(PUFAs + MUFAs)/SFAs

(PUFAs + MUFAs)/SFAs

≥ 2.5

≤ 1.2

≤ 1.8 oz equiv. per 1,000

≥ 4.3 oz equiv. per 1,000

kcal

kcal

Moderation:
Refined grains

10

Sodium

10

≤ 1.1 gram per 1,000 kcal

≥ 2.0 grams per 1,000 kcal

Empty calories9

20

≤ 19% of energy

≥ 50% of energy

Kcal, kilocalories; Equiv., equivalent; SFAs, saturated fatty acids; MUFAs,
monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids.
1

Intakes between the minimum and maximum standards are scored proportionately.

2

Includes 100% fruit juice.

3

Includes all forms except juice.

4

Includes any beans and peas not counted as total protein foods.
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5

Includes all milk products, such as fluid milk, yogurt, and cheese, and fortified soy

beverages.
6

Includes beans and peas when the total protein foods standard is otherwise not met.

7

Includes seafood, nuts, seeds, soy products (other than beverages), and beans and peas.

8

Ratio of poly- and monounsaturated fatty acids to saturated fatty acids.

9

Calories from solid fats, alcohol, and added sugars; threshold for counting alcohol is >

13 grams/1,000 kcal.
National Cancer Institute. (2020). Developing the healthy eating index. Retrieved July 7,
2020 from https://epi.grants.cancer.gov/hei/developing.html#2010c
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